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Neuronal functions critically depend on a continuous supply of glucose as prolonged 
hypoglycemia can lead to severe brain injury. It is surprising that except for astroglial glycogen 
the brain has no visible energy reserves. Myelin is a lipid-rich membrane that enwraps axons 
for fast impulse conduction. Myelinating oligodendrocytes also provide metabolic support to 
axons. We thus hypothesized that under starvation conditions myelin itself might support the 
white matter energy balance. Using the mouse optic nerve as a model, we found that 
oligodendrocytes but not astrocytes survive glucose deprivation ex vivo for up to 24 hours. In 
addition, myelin thickness was observed to decrease under starvation conditions and beta-
oxidation inhibition was shown to induce massive cell death in the optic nerve. These 
observations suggest fatty acids (FAs) released from myelin are involved in supporting cell 
survival under starvation Importantly, using electrophysiology combined with live imaging we 
showed that FA metabolism supports axonal ATP production and nerve conduction by 
perturbing beta-oxidation. This axonal support depends on FA beta-oxidation involving 
peroxisomes in the myelin compartment. To study reduced glucose availability in live mice, we 
deleted GLUT1 (Slc2a1) from mature oligodendrocytes, which led to slowly progressive loss of 
myelin. We therefore suggest a revised model for the dual function of oligodendrocytes, with 
myelin constituting an energy buffer that can prevent axonal degeneration when glucose 
availability is perturbed. These findings may be relevant for myelin abnormalities found in a 




















1.1 Glucose metabolism  
1.1.1 Glycolysis  
Glycolysis produces ATP, the energy currency of the cells, by breaking down glucose into 
two molecules of pyruvate. Glycolysis, an oxygen-independent process, takes place in the 
cytosol of the cell and it is known to be the only way a cell produces ATP without the need for 
mitochondrial oxidation. Glucose, the main source of energy for most of the cells, is taken up 
and transported in their cytosol via glucose transporters (GLUT1-5). As soon as glucose enters 
the cell, one molecule of ATP is readily used by the enzyme hexokinase to phosphorylate 
glucose on its C6 and glucose 6-phosphate is produced. When phosphorylated, glucose cannot 
leave the cell because of the newly acquired negative charge and, because of its different 
molecular composition, it maintains glucose gradient across the cell. Glucose 6-phosphate can 
1) be stored into glycogen 2) go through glycolysis for ATP production or 3) enter the pentose 
phosphate pathway. Following the glycolytic path, glucose 6-phosphate is subsequently 
converted to fructose 6-phosphate that is in turn phosphorylated by phosphofructokinase 
(PFK1, a key enzyme that regulates glycolysis), by consumption of another molecule of ATP: 
fructose 1,6-bisphosphate is hence formed. Then, enolase converts fructose 1,6-bisphosphate 
into 2 molecules of glyceraldehyde 3-phosphate. In the following step, glyceraldehyde 3-
phosphate dehydrogenase produces 1,3-bisphosphoglycerate (1,3-BPG) from glyceraldehyde 
3-phosphate. During this conversion, two molecules of NADH are produced by the co-
reduction of NAD+. The conversion of 1,3-BPG to 3-phosphoglycerate goes along with the 
production of two molecules of ATP. Acting phosphoglycerate mutase and enolase result in 
the formation of phosphoenolpyruvate from 3-phosphoglycerate and, in the last step of 
glycolysis, two more ATP molecules are produced, upon conversion of phosphoenolpyruvate 
to pyruvate. In glycolysis, per each molecule of glucose, two ATP molecules are consumed and 
four molecules of ATP, two molecules of NADH and two molecules of pyruvate are produced 






1.1.2 Tricarboxylic acid cycle and oxidative phosphorylation 
In the absence of oxygen, the glycolytic product, pyruvate, can be converted into lactate 
or ethanol depending on the organism. However, under aerobic conditions, pyruvate, can be 
transported into mitochondria for further oxidation and ATP production: the process is known 
as oxidative phosphorylation (OX-PHOS). Pyruvate transport into mitochondria is operated by 
the pyruvate carrier, an antiporter that transfers pyruvate from the cytoplasm into the 
mitochondria matrix in exchange for OH-. In the matrix of mitochondria, the pyruvate 
dehydrogenase complex converts pyruvate into one molecule of CO2, one of acetyl-CoA and 
one molecule of NADH through reduction of NAD+. The produced acetyl-CoA, in turn, enters 
the tricarboxylic acid (TCA) cycle upon condensation with oxaloacetate and formation of citric 
acid, a reaction that is catalyzed by citrate synthase. The cycle continues by isomerization of 
citrate to isocitrate that, following two decarboxylation steps, is converted into alpha-
ketoglutarate and succinyl-CoA respectively. In total, two molecules of CO2 and two molecules 
of NADH are generated. Then succinate is detached from -CoA, a reaction that produces one 
molecule of GTP (that can be converted into ATP). In the next step, succinate is converted into 
fumarate by succinate dehydrogenase and one molecule of FADH2 is produced. Fumarate 
undergoes a hydration reaction and L-malate is formed. Finally, malate is oxidized to 
oxaloacetate and a third molecule of NADH is formed. The regenerated oxaloacetate is now 
available to accept another molecule of acetyl-CoA for the initiation of a new cycle (Jeremy M 
Berg, John L Tymoczko, 2002) (Fig. I).  
The electron transport chain (ETC) is coupled with the TCA cycle through the 
regeneration of NAD+ from NADH that generates a proton gradient across the inner 
mitochondrial membrane, the gradient is used by the ATP-synthase to power ATP production. 
In the inner membrane of the mitochondria, five protein complexes take part in the ETC, of 
which the first four are involved in the generation of the proton gradient across the membrane. 
In fact, these complexes accept the electrons from NADH and FADH2, generated by glycolysis 
and TCA cycle, and transfer them to the ultimate acceptor of electrons, oxygen, to produce 
H2O. This process is accompanied by the pumping of protons from the matrix of mitochondria 





protons, provides the complex-V with the required energy for ATP synthesis. It is estimated 
that each molecule of NADH and FADH2 produces 2.5 and 1.5 molecules of ATP respectively.  
Therefore, it is estimated from one molecule of acetyl-CoA, 10 molecules of ATP are produced 
under aerobic conditions (Jeremy M Berg, John L Tymoczko, 2002).   
 
1.2 Fatty acid metabolism 
1.2.1 Fatty acids 
FAs play an important role in energy homeostasis in the body during a metabolically 
challenging condition (Houten et al., 2016). These compounds are essential monomeric 
components of all different classes of lipids (including triacylglycerols (TAGs), phospholipids, 
sterol lipids, and sphingolipids). FAs are composed of a carbon chain that terminates with a 
carboxylic acid functional group (-COOH). They are very diverse in their carbon chain length, 
and the saturation status on their chain makes them even more diverse (Tracey et al., 2018). 
Based on the number of carbon atoms in their backbone FAs are classified into four groups 
although the definition for each group might differ among researchers: 1) short-chain FAs 
(SCFAs) composed by less than seven carbon atoms; 2) medium-chain FAs (MCFAs) with 7-12 
carbon atoms in their structure (Schönfeld and Wojtczak, 2016); 3) long-chain FAs (LCFAs) with 
12-20 carbons and 4) FA with more than 20 carbons in their backbone, considered as very-
long-chain FAs (VLCFAs) (Kihara, 2012). 
 
1.2.2 Extracellular and intracellular sources of fatty acids 
It is postulated that the transport of FAs into the cells happens via two mechanisms: 1) 
passive diffusion (referred to as flip-flop model): a non-ATP consuming process whose 
efficiency depends on the size and lipophilicity of the FAs (e.g. the diffusion of SCFAs and 
MCFAs is easier than LCFAs) and 2) protein-mediated transport of FAs with high specificity for 
LCFAs and VLCFAs. There are known proteins involved in the latter process, including FA 
translocase (FAT/CD36) and plasma membrane FA-binding protein, or FABPpm (Houten et al., 





caveolin1 (Mitchell et al., 2011). FAT/CD36 was discovered in 1993 as a protein involved in the 
transport of LCFAs in rat adipocytes (Abumrad et al., 1993). In 2004, Phol and colleagues 
reported disruption of lipid rafts by applying beta-cyclodextrin or overexpression of a 
dominant-negative mutant of caveolin-3,  impairs uptake of VLCFAs into 3T3-L1 adipocytes 
(Pohl et al., 2004). In their following studies, the authors could show that FAT/CD36 specifically 
localized in lipid rafts and there was no synergistic effect between disruption of lipid rafts and 
FAT/CD36 inhibition on FA uptake. Based on these observations, a model describes how 
FAT/CD36, from intracellular nonlipid raft domains, can be recycled to the lipid raft 
microdomains in the plasma membrane. The process seemed to be involved in caveolin-1 
function according to evidence shown in mouse embryonic fibroblasts, obtained later in 2006 
by Ring (Pohl et al., 2005; Ring et al., 2006). FATP1-6 are bifunctional proteins that, besides 
their role in FA uptake, show acyl-CoA synthetase activity. FABP proteins are also classified into 
membrane-associated FABPs and cytosolic ones. The first group is not well understood and 
seems to be present on the extracellular surface of the plasma membrane as the treating of 
hepatocytes with trypsin shows to decrease the uptake of LCFAs (Stremmel et al., 1986). The 
cytosolic group of FABP proteins has been investigated more deeply: this family of proteins 
appears to be highly conserved among different species, from Drosophila melanogaster and 
Caenorhabditis elegans to mice and humans (Makowski and Hotamisligil, 2004). The first 
reported member of FABP proteins is FABP-1 (Liver- FABP), with a very high level of expression 
in tissues like liver, intestine, and kidney (2-5% of cytosolic proteins) (Atshaves et al., 2010). 
FABPs reversibly bind to FAs and are highly expressed in cells that are active in uptaking and 
metabolizing FAs. Several roles for FABP have been reported, including: 1) increasing FA uptake 
by cells, 2) protecting cells from toxic effects of LCFAs (like detergent effect and inhibitory 
effect on enzymes), 3) enhancing intracellular transport of FAs and their distribution among 
different organelles (including mitochondria and peroxisomes for metabolism), 4) transport of 
LCFAs to the nucleus for interaction with nuclear receptors involved in metabolism, e.g. PPARα 
(Makowski and Hotamisligil, 2004; Atshaves et al., 2010). 
Although several proteins and cellular machinery involved in the uptake of FAs have been 
discovered, the exact mechanism of action of FAT/CD36 and other components of FA uptake 





Besides the uptake of FAs from the extracellular space, other sources of FAs are present 
inside the cell: lipid droplets. These are intracellular organelles containing neutral FAs, sterol 
esters carrying a polar lipid monolayer on the surface, and proteins involved in the metabolism 
of FAs (Nishimoto and Tamori, 2017). These organelles are formed in the endoplasmic 
reticulum, where neutral lipids are synthesized. When needed, the FAs stored in lipid droplets 
and intracellular membranes are released as endogenous sources of FAs that can be mobilized 
for ATP production (Welte and Gould, 2017). The release of FAs from lipid droplets is performed 
either by lipid droplet associated lipases or by lipophagy, the process of autophagy of lipid 
droplets (Zechner et al., 2012). Autophagy is a process during which cytoplasmic materials are 
digested in lysosomes. This phenomenon is induced under metabolic stress such as starvation 
that results in increase in digestion of nonessential cellular materials to acquire energy 
metabolites for ATP production. There are three different types of autophagy: 1) chaperone-
mediated autophagy in which proteins are directly imported into lysosomes for degradation, 
2) microautophagy in which cytoplasmic materials are engulfed by lysosomal membrane and 
are digested in the lysosome and 3) macroautophagy a process during which a double 
membrane is formed around the targets and autophagosome is formed that later upon fusion 
with lysosome the targeted materials are digested (Glick et al., 2010). Under feeding state, the 
mammalian target of rapamycin1 (mTORC1) is active and phosphorylates transcription factor 
EB (TFEB), a master regulator of autophagy. When TFEB is phosphorylated, its translocation into 
nucleus is inhibited. Under starvation conditions, mTORC1 is detached from the lysosomal 
membrane and is inactive, therefore, TFEB is dephosphorylated and is translocated into the 
nucleus, where it induces transcription of several genes involved in autophagy and lysosomal 
biogenesis  (Sardiello et al., 2009; Settembre et al., 2011). 
 
1.2.3 β-Oxidation of fatty acids in mitochondria and peroxisomes 
Degradation of FAs in mitochondria is essential for the energy homeostasis of the cells, 
particularly during metabolic stress conditions, such as fasting and exercise (Chegary et al., 
2009). Beta-oxidation starts with the activation of FAs, an esterification reaction in which 





can be transported into either mitochondria or peroxisomes for beta-oxidation (Houten et al., 
2016; Tracey et al., 2018). 
1.2.4 Import of fatty acids into mitochondria 
Depending on their chain length, the mechanism of transport of FAs into mitochondria 
is different. Short and medium-chain FAs enter mitochondria by diffusion and are activated in 
the matrix of mitochondria. However, the mitochondrial membrane is impermeable to LCFAs 
(and acyl-CoA) and their transport into mitochondria is mediated by the carnitine shuttle 
(Wanders et al., 2010). The components of FA import into mitochondria are 1) carnitine (β-
hydroxy-γ-trimethylammonium butyrate) that is taken up into the cells by high-affinity organic 
cation transporter novel 2 (OCTN2), and 2) three proteins including carnitine palmitoyl-
transferase 1(CPT-1), carnitine acyl-carnitine translocase (CACT) and carnitine palmitoyl-
transferase 2 (CPT-2). 
Carnitine palmitoyl-transferase 1 (CPT-1) is an integral membrane protein, located in the 
outer membrane of mitochondria and it is the only enzyme in the mitochondrial FA-oxidation-
system that exists in tissue-specific isoforms. This enzyme converts long chain acyl-CoA into 
long chain acyl-carnitine. Three isoforms for this enzyme have been reported, CPT1a and CPT1b 
which are called liver-type and muscle-type respectively, and CPT1c, another isoform reported 
to be neuron-specific. However, CPT1c enzymatic activity and its role in lipid metabolism are 
not clear yet (Wolfgang, 2016). In the next step of import, carnitine acyl-carnitine-translocase 
(CACT), an antiporter located in the inner mitochondria membrane, transfers one acyl-carnitine 
molecule into the matrix of mitochondria, in exchange with one molecule of carnitine. This 
antiporter is not solely specific to long-chain acyl-CoA and has been reported to be involved 
in the transport of short-chain acyl-carnitines, such as acetyl-carnitine and propionyl-carnitine 
produced in peroxisomes (Wanders and Waterham, 2006). CPT2 is a protein loosely associated 
with the inner face of the inner mitochondrial membrane, and it reconverts acyl-carnitine into 







1.2.5 Mitochondrial β-Oxidation system 
β-Oxidation is a cyclic process that degrades FAs into acetyl-CoA units. The beta-
oxidation process can be divided into four steps: 1) dehydrogenation, 2) hydration, 3) 
dehydrogenation and 4) thiolytic cleavage.  
Dehydrogenation of acyl-CoA molecules during the first step of beta-oxidation is 
performed by acyl-CoA dehydrogenase (ACAD). Three ACAD enzymes have been identified: 
based on their specificity for their substrates, are called short-chain acyl-CoA dehydrogenase 
(SCAD), medium-chain acyl-CoA dehydrogenase (MCAD) and long-chain acyl-CoA 
dehydrogenase (LCAD). All these enzymes use flavin adenine dinucleotide (FAD) as a coenzyme 
and upon their activity, FADH2 and trans-2-enoyl-CoA are formed (Swigoňová et al., 2009). 
Recently ACAD9, a new acyl-CoA dehydrogenase, has been reported. ACAD9 plays an 
important role in the assembly of complex I in mitochondria, along with its dehydrogenase 
activity on long-chain acyl-CoA (Zhang et al., 2002; He et al., 2007; Schiff et al., 2014).  
In the second reaction of beta-oxidation, which is catalyzed by enoyl-CoA hydratases, 
one molecule of H2O is added to the existing double bond in 2-enoyl-CoAand 3-hydroxyenoyl-
CoA is formed. There are two proteins catalyzing this reaction: 1) long-chain enoyl-CoAs 
hydratase, as part of the mitochondrial trifunctional protein (MTP) which acts on long straight-
chain enoyl-CoAs, with the highest activity on C16:1 substrate and 2) crotonase that acts on 
short-chain enoyl-CoAs. enoyl-coAs with 4 to 16 carbon in their backbone, are substrates for 
crotonase. However, the activity of crotonase decreases with the increase in chain length of 
enoyl-CoAs. Since long chain enoyl-CoAs hydratase does not act on crotonyl-CoA it has been 
suggested that crotonase is needed at least for handling crotonyl-CoA. 
The third step of beta-oxidation is the conversion of L-3-hydroxyenoyl-CoA to 3-
ketoacyl-CoA. This reaction is catalyzed by two 3-hydroxyacyl-CoA dehydrogenases: 1) long-
chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD), that is part of MTP with its highest activity 
on C16 substrates and no activity on C4 substrates. 2) short-chain 3-hydroxyacyl-CoA 
dehydrogenase (SCHAD) which acts on substrates with 4 to 16 carbon in their backbone. 
The last step of beta-oxidation is the cleavage of 3-ketoacyl-CoA and the formation of 
acetyl-CoA and shortened acyl-CoA. Three Ketoacyl-CoA thiolases have been identified in 





on substrates with 6 to 16 carbon atoms in their backbone, 2) medium chain 3-Ketoacyl-CoA 
thiolase (MCKAT), 3) beta-ketothiolase that uses 2-methylacetoacetyl-CoA as unique substrate 
and plays an indispensable role in isoleucine degradation (Wanders et al., 2010). 
The shortened acyl-CoA produced at the end of each cycle of beta-oxidation could 
undergo a new cycle(s) of beta-oxidation till it is completely breakdowns into acetyl-CoA.  
The end product of beta-oxidation, acetyl-CoA, and propionyl-CoA, could have different 
fates. acetyl-CoA can enter the TCA cycle for complete degradation into CO2 and production 
of ATP, NADH, and FADH2 as explained before in the glucose metabolism section. All FADH2 
and NADH, produced during beta-oxidation and complete degradation of acetyl-CoA in the 
TCA cycle, can transfer their electrons into the electron transport chain, for the generation of a 
proton gradient across the inner mitochondrial membrane, used for ATP production (Tracey et 
al., 2018).  
The propionyl-CoA that is produced upon degradation of odd-numbered carbon chain 
molecules, can be carboxylated and converted into succinyl-CoA (intermediate of TCA cycle) 
via three reaction steps (Mazumder et al., 1961) (Fig. I). 
 
1.2.6 Peroxisomes 
For the first time, the term “Microbodies” was used in 1954 by Johannes Rhodin, to report 
the presence of single membrane cytoplasmic bodies observed on micrographs of convoluted 
tubule cells of the mouse kidney. Two years later, the presence of microbodies in rat liver tissue 
was reported by Rouiller and colleagues. (Rouiller and Bernhard, 1956). Later on, de Duve’s 
group isolated microbodies from the rat liver, and by studying their biochemical properties, 
they found the presence of several enzymes involved in the production and degradation of 
hydrogen peroxide. These microbodies were termed “peroxisomes”.(Gabaldón, 2010; De Duve, 
1996) . Soon after, a specific cytochemical staining for the detection of peroxisomes with light 
and electron microscopy was developed with the introduction of the alkaline 3, 3′-
diaminobenzidine (DAB) reaction for catalase (Novikoff and Goldfischer, 1969).). Since then, 
the presence of these organelles was reported in other species and, like mitochondria, 





and Fahimi, 2008a). Further studies showed substantial differences in peroxisomes between 
different organisms and even within the same organism, peroxisome’s properties can differ 
between organs (Titorenko, 2001). In mammals, peroxisomes play an important role in cellular 
lipid metabolism including 1) FA beta-oxidation, 2) ether phospholipid (plasmalogen) 
biosynthesis, 3) FA alpha-oxidation 4) biosynthesis of cholesterol, 5) bile acids, 6) 
prostaglandins (Titorenko, 2001). as well as 7) cellular redox balance (Schrader and Fahimi, 
2008a). In terms of their size, peroxisomes also show differences that range from 0.1- 1.0 μm 
(Schrader and Fahimi, 2008b).  
 
1.2.7 Peroxisomal beta-oxidation 
The degradation of more complex FAs takes place in peroxisomes. Since very long-chain 
acyl-CoA(s) are not substrates of the carnitine shuttle in the membrane of mitochondria, this 
group of FAs cannot enter these organelles and their degradation is limited to peroxisomes 
(Longo et al., 2016). In mammals, three ATP- binding cassette (ABC) transporters (subfamily D) 
in the membrane of peroxisomes are responsible for the import of FAs into peroxisomes. All 
three transporters use acyl-CoA as substrate and, during the transport, remove CoA and release 
free FAs into the lumen of the peroxisome. Acyl-CoA synthases interacting with transporters 
regenerate acyl-CoA (Longo et al., 2016; Theodoulou et al., 2016). Acyl-CoA undergo beta-
oxidation inside peroxisomes: this process is basically similar to beta-oxidation in mitochondria 
and consists of four reactions, including dehydrogenation, hydration, dehydrogenation, and 
thiolytic cleavage. However, the enzymes that catalyze the reactions are different. The first step 
is catalyzed by acyl-CoA oxidase (ACOX) instead of acyl-CoA dehydrogenase in mitochondria 
and the removed hydrogens are used for the formation of H2O2, subsequently converted to 
H2O by catalase. ACOX1 (isoform a and b), ACOX2 and ACOX3 catalyze this step. Steps two 
and three are catalyzed by multifunctional proteins, MFP1 and MFP2. The activity of MFP1 
results in products with L- configuration while MFP2 generates end products with D- 
configuration. The formed trans-2-enoyl-CoA in step one is hydrated by MFP1 and MFP2 and 
3-hydroxy-acyl-CoA is produced. This is a substrate for the 3-hydroxy-acyl-CoA 





of 3-ketoacyl-CoA during the third step results in the formation of one molecule of NADH. In 
the last step, Ketoacyl-CoA thiolase removes acetyl-CoA from 3-Ketoacyl-CoA and acetyl-CoA 
and shortened acyl-CoA are formed (Baes and Van Veldhoven, 2012). The end products of 
beta-oxidation in peroxisomes are acetyl-CoA, propionyl-CoA and shortened acyl-CoA that 
could be converted to carnitine esters. Two enzymes are involved in this conversion: 
carnitineoctanoyl transferase (CROT) and carnitine acetyltransferase (CRAT) that seem to be 
involved in the export of beta-oxidation products from peroxisomes (Baes and Van Veldhoven, 
2012; Westin et al., 2008).The machinery involved in export of FAs from peroxisomes remains 
largely unknown, however, OCTN3 might be a promising candidate as it is a carnitine 
transporter localized in the peroxisomal membrane (Lamhonwah et al., 2005). It has also been 
suggested to be involved in export of end products of beta oxidation (acyl-carnitine) from 
peroxisomes (Januszewicz et al., 2009).  
 
1.2.8 Interaction between peroxisomes and mitochondria 
The complete degradation of peroxisomal beta-oxidation products for the generation of 
ATP depends on their interaction with mitochondria.  Although the peroxisomal beta-oxidation 
is very similar to the mitochondrial one, the purpose of this process in peroxisomes is the 
shortening of FA chain length (Baes and Van Veldhoven, 2012; Longo et al., 2016; Tracey et al., 
2018). For example, rat liver peroxisomes do not use butyryl-CoA as substrate and their activity 
is less with octanoyl-CoA than with lauroyl-CoA or palmitoyl-CoA (Lazarow, 1978). In addition, 
degradation of VLCFAs is restricted to peroxisomes and only after shortening these can be a 
substrate for mitochondrial beta-oxidation (Violante et al., 2013). Moreover, since peroxisomes 
do not carry the enzymatic machinery for the TCA cycle and the ETC, the complete degradation 
of FA to CO2 and ATP never takes place inside this organelle. Therefore, transfer of end products 
of peroxisomal beta-oxidation including acetyl-CoA, propionyl-CoA, and shortened FAs into 










figure I. Glucose metabolism and interaction between peroxisomal and mitochondrial beta-oxidation. Glucose enter 
the cells via GLUT transporters and upon glycolysis is converted into pyruvate (upper right corner). Inside the 
mitochondria, pyruvate is converted to acetyl-CoA that enters the TCA cycle (blue arrows) for further degradation 





lipid droplets and intracellular membranes) or they can be up taken by cells by FAT/CD36 proteins present in the 
plasma membrane. After activation in the cytoplasm (conversion to acyl-CoA), these precursors enter 
mitochondria or peroxisomes for beta oxidation. Entry of SCFAs and MCFAs into mitochondria is performed by 
diffusion, however, import of LCFAs is dependent on carnitine/acyl-carnitine transport system (since VLCFAs are 
not substrate for CPT1, degradation of VLCFAs do not occur in mitochondria). When in the matrix of mitochondria, 
FA can undergo beta-oxidation (brown arrows, lower right corner) that results in the production of FADH2, NADH, 
and the formation of acetyl-CoA and shorter chain acyl-CoAs (-2C). The produced acetyl-CoA during beta oxidation 
can enter the TCA cycle for complete degradation. Degradation of FAstake place in peroxisomes (in purple) as well 
and degradation of VLCFAs is restricted to peroxisomes. Since peroxisomes are devoid of TCA cycle and ETC, after 
beta-oxidation in peroxisome, the chain shortened FAs, acetyl-CoA and other end products should enter 
mitochondria for ATP production (unknown mechanisms: proteins like CROT, CRAT and OCTN3 might involve in 
this process). Therefore, it is generally accepted that the interaction between these two organelles is necessary 
for ATP production. The produced FADH2 and NADH in TCA cycle or beta-oxidation are used by the ETC in the 
inner mitochondrial membrane to establish a proton gradient that is necessary for ATP generation during OX-
PHOS. 
 
1.3 Metabolism in WM 
1.3.1 WM energy demands - glucose metabolism 
The structure and the organization of white matter (WM) are different than those of gray 
matter (GM), therefore the energy demands and regulation of metabolism are different too. In 
WM tracts, the dendrite of neurons that form synapses (axon-axonal synapses) for signal 
processing are not densely present and only recently it has been reported that axon-
oligodendrocyte precursor cell (OPC) synapses are present during development and may also 
exist after myelination is complete (Kukley et al., 2007; Ziskin et al., 2007). However, it is not 
known whether the amount of energy that is required by an axon-OPC synapse in WM is 
comparable with axon–axon synapse of gray (Harris and Attwell, 2012). 
The absence of dendrites and therefore the lack of the most energy-consuming part of a 
neuron reduces the energy demand of WM significantly (Sokoloff and Clarke, 1989). Despite 
the lower energy demand of WM, even under physiological conditions, processes like 
regeneration of resting potential along the axons, transport of organelles and proteins to the 
synaptic terminal as well as the maintenance of housekeeping functions, pose a metabolic 
challenge for axons and glial cells of WM (Harris and Attwell, 2012; Baltan, 2014). In addition, 
two WM structural features make energy metabolism even more complex: 1) the vascular 
network in WM is less dense than gray matter, reducing blood supply in this region (Moody et 
al., 1990); 2) the presence of myelin, a multilayer structure of phospholipids that is formed by 





increases the resistance (and lower the capacitance) of the axonal membrane but at the same 
time, it restricts the axons to have access to extracellular metabolites, with the exception of the 
node of Ranvier (Nave, 2010).  
In 1994 Pellerin & Magistretti described the details of a model through which astrocytes 
support neurons, astrocyte-neuron lactate shuttle hypothesis (ANLSH). Based on this model, after 
release of glutamate from presynaptic neurons, the nearby astrocyte processes start removing 
glutamate via sodium co-transporters that results in an increase in intracellular Na+ concentration 
in astrocytes and activation of Na/K ATPase pumps. The sudden increase in the ATP demand of 
astrocytes lead to increase in uptake of glucose from vasculature that after conversion into lactate 
are shuttled to neurons (Pellerin and Magistretti, 1994). The most parts of the machinery and 
required structures for the astrocyte-neuron lactate shuttle transfer system are present in WM and 
increasing evidence supports the hypothesis of astrocytic metabolic support of axonal function 
(Lee et al., 2012; Hirrlinger and Nave, 2014a; Fünfschilling et al., 2012; Saab et al., 2016; Trevisiol et 
al., 2017). It has been reported that astrocytes with their end-feet in proximity to vasculature, are 
present at the nodal region in the central nervous system and these perinodal astrocytes can even 
form junctions with the axonal membrane trough glycoproteins involved in cell-cell interaction, 
like J1, N-CAM, cytotactin and extracellular matrix components produced by glial cells (Black and 
Waxman, 1988). The expression pattern of monocarboxylate transports, MCTs, has also shown that 
MCT1, expressed in lactate producing tissues is expressed by astrocytes and MCT2 that seems to 
be more involved in the uptake of lactate, is present in the axonal membrane (POOLE et al., 1996; 
Bröer et al., 1997). The Lactate dehydrogenase isozymes, an enzyme that converts lactate to 
pyruvate and vice-versa, LDH5 and LDH1 show also a specific expression pattern: LDH5, that favors 
more the conversion of pyruvate to lactate, is expressed in astrocytes and LDH1, that rather 
converts lactate to pyruvate (that feeds the TCA cycle) is abundant in the axonal compartment 
(Bittar et al., 1996). These studies have been supported by functional observations obtained from 
electrophysiology ex-vivo measurements in the optic nerve (used as a model for a WM tract (Stys 
et al., 1991), where the conduction of all firing axons is presented as compound action potential 
(CAP). In the optic nerve, the majority of axons are myelinated, and astrocytes are the only cells 
that contain glycogen as the storage form of glucose. When glucose is removed from the solution 





conduction for as long as 20 min, by degrading the stored glycogen in astrocytes. Astrocytes 
under glucose deprivation can, in fact, produce and release lactate that is uptaken by the axon via 
MCT2 for ATP production (Brown et al., 2004). Furthermore, it has been observed that lactate, as 
the end product of glycolysis, is capable of maintaining the nerve function as good as glucose, 
indicating that lactate can be used by axonal mitochondria for ATP production (Brown et al., 2003). 
 
1.3.2 Effect of myelination on signal propagation and energy utilization in WM 
In the central nervous system, oligodendrocytes form the myelin sheath around the axon. 
The term ‘myelin’ was coined for the first time by Rudolf Virchow in 1854 under the assumption 
that myelin was made by neuronal secretions. Later on, in 1921, by the advance in histological 
techniques, Pio del Rio-Hortega re-discovered oligodendrocytes (after Robertson in 1899) and 
called them oligodendroglia. In 1924 Penfield, jointly with del Rio-Hortega, hypothesized that 
myelin could be made by oligodendrocytes. Finally, in 1954 Geren could show that Schwann 
cells form myelin in the peripheral nervous system. Following on this observation, in 1962, 
Bunges could prove that myelin in the CNS is formed by oligodendrocytes. Each 
oligodendrocyte in the CNS can make contact with 20 to 60 points on the axons where they 
form myelin segments stretching for ̴ 20 to 200 µm longitudinally. These stretches of myelin 
are separated by nodes of Ranvier (Simons and Nave, 2016).  
The best-known function of myelin is the increase in the speed of action potential (AP) 
propagation along the axon. The electrical properties of axons are determined by the presence 
of a negative electric potential across the plasma membrane due to a separation of charges, 
which is in turn created by the different concentrations of ions (K+, Na+, Cl- and Ca2+) across 
the cell membrane. The membrane potential of all cells is reported to be typically between -30 
to -70 mV. This potential does not change with time in most mammalian cell types, with the 
exception for neurons and muscle cells that are electrically active. Under resting conditions, 
there is a potential across the axonal membrane of around -70 mV. This negative potential is 
the consequence of an electrochemical gradient that is produced by the Na+/K+ATPase pumps 
that distribute K+ and Na+ ions differently across the membrane so that the K+ concentration 





value of resting membrane potential, the voltage-gated ion channels are closed, but when this 
value changes towards more positive values (approaching the threshold), the depolarization 
can trigger an AP that involves the activity of Na+ and K+ voltage-gated channels. The AP has 
three phases including depolarization, hyperpolarization and return to the resting potential. In 
the first phase, the membrane potential in a region of the neuron (e.g. dendrite or axon hillock) 
depolarizes slightly (due to activation of postsynaptic ionotropic receptors or in response to 
integration of EPSP). By reaching the threshold of stimulation, the voltage-dependent Na+ 
channels open for a short period of time resulting in an influx of Na+ ions and depolarization 
associated with the rise of an AP. Because the voltage-gated K+ channels open at more positive 
values of Rm and with sub-millisecond delay after the initial depolarization, this kind of voltage-
gated K+ channels are also called delayed K+ channels and are responsible for the 
hyperpolarization phase, or second phase of the AP. Eventually, all the voltage-gated channels 
are closed and only non-voltage-gated K+ channels that generate the negative potential of the 
membrane open (rectifying) and the potential of the membrane reaches the resting state after 
a short hyperpolarization phase. At the peak of the AP, the membrane depolarization is 
sufficient to passively spread downstream of the segment of membrane involved in the AP 
producing a propagation wave of the AP. The upstream propagation is prevented by the 
refractory period of the membrane (off-state of the ion channels). Although the activity of the 
Na+/K+ ATPase does not directly play a role in the AP generation, and the nerves can normally 
fire thousands of time in the absence of ATP (since the ion flow across the membrane during 
each discharge causes only a minute change in concentration of Na+ and K+ ions), the 
continuous generation of AP requires the activity of the Na+/K+ ATPase to restore the gradient 
of ions across the membrane (Lodish H, Berk A, Zipursky SL, 2000). This process has a cost in 
ATP molecules and is by far the most energy-consuming feature in the axon (Harris and Attwell, 
2012). The alternation of myelinated vs. naked axon segments results in the propagation of AP 
from one node to the next is referred to as salutatory propagation, as opposed to the wave 
propagation and consequently, increases the speed of signal propagation along the axons 
(Hirrlinger and Nave, 2014a).  
Myelination affects not only the velocity of signal propagation along the axon, but also 





axons except for the nodes of Ranvier, therefore a large percentage of Na+ channels are not 
involved in the influx of Na+ during AP propagation. Therefore, based on our current 
understanding and available models, the consequence of minimizing the Na+ influx is saving 
energy (Waxman, 1997; Hartline and Colman, 2007; Harris and Attwell, 2012). However, the 
conclusion on a putative energy-saving feature conferred by myelin of WM tracts is still under 
debate, given that the amount of energy needed for maintaining the myelin structure itself is 
not clear yet. 
Besides the clear advantage of myelination in speeding AP propagation, covering the 
axons with myelin sheath makes also an effective barrier on the surface of the axon and limits 
the accessibility of myelinated segments to the extracellular space and its metabolites 
(Hirrlinger and Nave, 2014b). In order to overcome this limitation introduced by compacted 
multilayer structure with low turnover, it is hypothesized that myelin has developed to support 
the ensheathed axon by directly providing metabolites (Nave, 2010). Therefore, it seems that 
myelin is not a merely passive structure but increasing evidences suggests that myelin rather 
supports axonal function by providing metabolites to the axons and plays an important role in 
long term integrity of axons in WM. Oligodendrocytes that strongly express MCT1 release 
lactate into the peri-axonal space (space between the axon and the oligodendrocyte’s adaxonal 
membrane) and support axonal function. Impairment in this support mechanism can affect the 
axonal function and integrity (Fünfschilling et al., 2012) as it has been reported in cases of MCT1 
downregulation, both in patients with amyotrophic lateral sclerosis (ALS) and in the murine 
model of the disease (MCT1 heterozygous mice) that resembles ALS symptoms and phenotype 
(Lee et al., 2012).This metabolic support by the oligodendrocyte needs to be finely tuned and 
adjusted on the energy demands of the axon. This is achieved by a constant communication 
between the axon and the oligodendrocyte that ensures that the axon receives enough 
substrates under constant activity (Saab et al., 2016). It has been shown that neurons form 
synapses with oligodendrocytes (referred to as Axo-Myelinic synapse) by releasing 
neurotransmitters along their axons and into the peri-axonal space (Douglas Fields, 2015). The 
axo-myelinic synapse activity correlates with neuronal activity. In 2016 Saab et al., using 
conditional knock-out mice lacking NMDA receptor in their oligodendrocytes, showed the 





glucose uptake by oligodendrocytes through translocation into the cell membrane of GLUT1, 
the main glucose transporter in oligodendrocytes (Saab et al., 2016).  
 
1.3.3 WM energy demands- fatty acid metabolism 
The brain is able to use FAs and its derivatives as a glucose-alternative fuel supply. 
Studies that used 13C labeled octanoate, estimated that around 20% of the energy in rats’ brain 
is coming from FAs under resting conditions (Ebert et al., 2003). Under specific conditions, 
when glucose is not enough to support brain metabolism, the role of FA catabolism becomes 
even more important and utilization of FAs and ketone bodies (as lipid derivatives) increases 
(Owen et al., 1967; Cahill, 2006; Klosinski et al., 2015). The fact that the brain can use FAs and 
its derivatives as fuel is well established (Ebert et al., 2003; Vignais et al., 1958).However, which 
cell types are involved in FA oxidation and under which condition FAs are used remains unclear. 
Studies on neuron, astrocyte and oligodendrocyte cultures from developing rat brain (1-2 days 
old) have shown that all three cell types are able to oxidize ketone bodies, while astrocytes 
were found to be the only cell type capable of oxidizing FAs to CO2 (Edmond et al., 1987; 
Auestad et al., 1991). These observations suggest that mitochondria in astrocytes are able to 
oxidase FAs during the suckling period. However, it remains unclear whether these 
observations can be extrapolated to mature brain cells.  
Peroxisomal beta-oxidation in myelin plays an important role in the health of the brain. 
The importance of peroxisomes in the brain has been reflected in neurodegenerative 
peroxisomal disorders. In several years, using genetic tools and generating mouse conditional 
knock-out, peroxisomes have been inactivated in a cell-specific manner. One of the targeted 
proteins for studying the role of peroxisomes is PEX5. PEX5 is part of the protein import 
machinery of peroxisomes that binds to the PTS1 signal sequence of peroxisomal proteins and 
targets them to the peroxisome. When PEX5 is knocked-out, the formed peroxisomes are 
lacking proteins in their lumen and thus are inactive. Inactivating peroxisomes in forebrain 
projection neurons (Pex5fl/fl * Nex-Cre mice) does not cause any phenotype in mice probably 
because of the rare abundance of this organelle in neurons. When peroxisomes are inactivated 





and ependymal cells. However, this does not affect neurological function as the mice do not 
show any phenotype (Bottelbergs et al., 2010). Interestingly, the consequence of peroxisome 
inactivation in myelin (CNP-Pex5−/− mice) is a severe phenotype that presents demyelination, 
axonal loss (without neuronal death) and neuroinflammation (Kassmann et al., 2007; Baes and 
Van Veldhoven, 2012b). Ultrastructural studies of CNP-Pex5−/− mice revealed an apparently 
normal myelin but presence of axonal swelling even before the onset of demyelination, 
implying that peroxisomes do not play an important role in myelination but their function is 
important for long term integrity of the axons that are far away from the soma of neurons 
(Kassmann et al., 2007). In addition, subcellular localization studies of peroxisomes have shown 
that the majority of peroxisomes are at the soma. However, peroxisomes can be present at the 
innermost and outermost layers of myelin and are accumulated in the paranodal region 
(Kassmann, 2014). These two observations along with 1) axonal swelling being a sign of energy 
deficit in axons (Ferreirinha et al., 2004) and 2) the presence of peroxisomes at the axo-glia 
interaction site (i.e. paranodes), has driven the authors to postulate an interaction between 
myelin-associated peroxisomes and moving mitochondria along the axons (Kassmann, 2014). 
Since in PEX5 mutants the cells contain inactive peroxisomes (Ghost peroxisomes), all the 
functions related to peroxisomal enzymes have been perturbed. Following studies that 
perturbed beta-oxidation in peroxisomes (e.g. by inactivating MFP2 in neural cells) showed 
that beta-oxidation plays an important role in peroxisomal disorders (Verheijden et al., 2013). 
Although these observations support the importance of peroxisomal beta-oxidation in myelin, 
there is no direct evidence showing the actual purpose of their function but speculations about 
their possible involvement in the turnover of membrane-associated FAs or, direct involvement 
in brain energy metabolism (Kassmann, 2014).    
There is evidence suggesting that endogenous brain lipids could serve as a source of energy. 
In this respect, myelin represents a highly FA-riched structure, formed by the layering of the 
plasma membrane of oligodendrocytes (in the CNS) around the axons. Myelin similarly to the 
membrane of other cells, is composed of proteins and lipids. However, myelin has uniquely 
high lipid content: around 70% of the dry-weight of myelin is composed of lipids (Chrast et al., 
2011; Ozgen et al., 2016). There are some observations suggesting that myelin is degraded 





in glucose metabolism has been reported in the brain of aged, schizophrenic and early stages 
of Alzheimer patients (de Leon et al., 1983; Mosconi, 2005; Yao et al., 2009; Chrast et al., 2011; 
Yang et al., 2017). This decline in glucose metabolism is followed by a shift to the utilization of 
FAs and ketone bodies as alternative fuels for the brain (Yao et al., 2010; Ding et al., 2013). 
Furthermore, this shift in metabolism is accompanied by changes in WM and myelin 
breakdown (Zhang et al., 2007; Lebel et al., 2012). Although these observations suggest that 
myelin-associated FAs are a source of energy under pathological conditions (Yao et al., 2011; 














Although it has been shown that FAs can be metabolized by the brain, the importance of FA 
catabolism has been neglected to some extent as glucose has been regarded as the major 
source of energy in the brain. In this project we aimed for answering following basic questions 
related to the role of myelin and beta-oxidation of FAs in supporting energy demand of 
neurons, a subject with potential implication in brain diseases: 
1) Glycogen, the storage form of glucose, is present in astrocytes to support brain function in 
time of need. In WM, oligodendrocytes wrap around the axons and form a multilayer structure 
enriched in FA called myelin. The best-known function of myelin is increasing the rate of signal 
propagation along the axon; however, it remains unclear whether myelin needs all its layers to 
exert is function or if it could still function normally by losing some of it layers as a source of 
energy. It therefore raises the question whether myelin is a storage form of FA that serves as a 
buffer of energy for the brain. 
2) Despite reported studies showing FAs are metabolized by the brain, it has not been shown 
if FAs could support nerve function. To address this question using ex-vivo electrophysiology 
of the optic nerve, we could show if beta-oxidation of FAs is involved in supporting nerve 
function.  
3) Even though, the importance of peroxisome in brain function has been clearly reflected in 
several diseases with impaired peroxisomal functions, the role of peroxisomes in supporting 












3.1. Results outlook: 
The results obtained from this project are explained in four sections that are closely 
related. In section one, the data regarding the evaluation of the mouse optic nerve (MON) as 
our model system and the effect of starvation on the viability of its different cell types will be 
reported. Section two includes the data suggesting that myelin-derived FAs are involved in 
supporting the survival of MON cells under starvation condition. In section three, we focus on 
the data supporting the role of FAs in nerve function. The acquired results from ex vivo 
electrophysiology combined with live imaging of MON and the effect of beta-oxidation 
inhibitors on the nerve function are reported in this section. The last section describes the 
obtained data from an in vivo mouse model for oligodendrocyte starvation, the GLUT1 ciKO 
mouse line, that shows how myelin is progressively degraded when glucose uptake is 
perturbed specifically in mature oligodendrocytes. 
   
3.2. Starvation effect on viability of mouse optic nerve cells 
3.2.1. Evaluation of the mouse optic nerve as a model system 
The mouse optic nerve (MON) is a suitable model for studying metabolism in WM. In the 
optic nerve, all axons are appropriately aligned and myelinated by oligodendrocytes. Therefore, 
it is easy to prepare longitudinal and cross-sections for histological studies and it is possible to 
use them for studying the function of the nerve by doing ex vivo electrophysiology.  
To evaluate the proper preparation of the nerve for histological studies, the optic nerves 
from wild type (WT) mice were incubated in aCSF containing 10 mM glucose (aCSF+10 mM 
glucose) for 16h and 24h and were stained with presidium iodide (PI) during incubation. PI is 
an impermeable dye that does not penetrate the cells with an intact plasma membrane and it 
only stains the nucleus of dead cells by intercalation into the DNA structure making it useful 
for detecting dead cells (Crowley et al., 2016). The obtained images from a longitudinal section 
of the incubated nerves revealed that the majority of cells are alive in the optic nerve and only 






nerve (fig. 1A and B).  Thank to Dr. Aiman Saab, Jennifer Günther and Annette Fahrenholz for 
teaching me the histology techniques. 
 
                                                    
Figure 1. Evaluation of the optic nerve preparation for incubation purpose. 
(A)  The images from longitudinal optic nerve sections (8-micron thick) of wild type mice after 16h (left) and 24h 
(right) incubation in aCSF + 10 mM glucose. The blue dots showing the nucleus of the cells were stained with DAPI 
and the red signal is PI that has been used for detecting the dead cells (Scale bar: 50 µm, frame Size: 200*150 µm). 
(B) Showing the quantified cells death in the whole longitudinal section from the optic nerve expressed in percent 
(ratio of PI / DAPI) after 16h and 24h. (Wild type mice, 8-9 weeks old, male or female, statistics: t-test, error bars: 
mean+/-SEM, n≥8).  
 
3.2.2. Effect of starvation on viability of optic nerve cells 
In order to evaluate the susceptibility of the optic nerve to starvation condition, MON 
from WT mice were incubated for different time points, 16h and 24h, in artificial cerebrospinal 
fluid (aCSF) containing 10 mM sucrose (aCSF+10 mM sucrose) instead of glucose. For the sake 
of simplicity, hereafter Glucose condition (Glc) refers to aCSF+10 mM glucose and starvation 
condition (Stv) refers to aCSF+10 mM sucrose for all the incubation experiments, unless 
otherwise stated. Our data shows that 16h-starvation does not affect the viability of optic nerve 
cells. However, 24h starvation induces death of 18.3% of optic nerve cells as reflected in the 
number of PI positive cells (Fig. 2A and B). These observations suggest that most of the cells in 
the optic nerve can tolerate starvation condition and raises the question of which cell types are 








Figure 2. Effects of 16 and 24h starvation on viability of optic nerve cells. 
(A) The images from longitudinal optic nerve sections (8 microm thick) of wild type mice after 16h (left) and 24h 
(right) incubation in aCSF + 10 mM sucrose (Stv). The blue dots showing the nucleus of the cells were stained with 
DAPI and the red signal is PI that has been used for detecting the dead cells during starvation (Scale bar: 50 µm, 
frame Size: 200*150 µm). (B) Is showing the quantified cells death in the whole longitudinal section from the optic 
nerve expressed in percent (ratio of PI / DAPI) after 16h and 24h starvation. (Wild type mice, 8-9 weeks old, male 
or female, statistics: t-test, error bars: mean+/-SEM, n≥8).  
 
3.2.3. Effect of starvation on viability of different cell types in the optic nerve 
In order to define which cell types are dying during starvation, the optic nerves from 
mouse lines expressing GFP or YFP in a cell-type specific manner were used. Since cell death is 
induced in the 24h-starved nerve (Fig. 2A, B), the nerves were incubated in aCSF + 10 mM 
glucose/ or sucrose for 24h. After staining the nerves with PI, they were fixed and subjected to 
microscopy. The obtained data revealed that the frequency of oligodendrocytes, 
oligodendrocytes precursor cells (OPCs), microglia and astrocytes in incubated optic nerve for 
24h under normal condition are around 53%, 5%, 6% and 23.5%, respectively and starvation 
has no significant effect on the population of the first three cell types. However, the number of 
quantified astrocytes has decreased to 10.61% under starvation conditions, accounting for 
death of 55% of astrocytes (Fig. 3A and B). Adding to this 55% of dead astrocytes the 
percentage of astrocytes that are still showing a weak green signal and are PI-positive result in 
final calculation of survival of only around 30% of the astrocyte population after 24h starvation 







Figure 3. Effects of 24h starvation on frequency and survival of different cell types in mouse optic nerve. 
(A) The images from longitudinal optic nerve sections (8 microm thick) of mice labled for specific cell types after 
24h incubation under normal (aCSF + 10 mM glucose (Glc), left column) and starvation condition (aCSF+10 mM 
sucrose (Stv), right column). The blue dots showing the nucleus of the cells were stained with DAPI and the red 
signal is PI that has been used for detecting the dead cells during starvation. The upper row is the images from 
Cnp-mEos-SKL mouse line that have labeled peroxisomes specifically in their oligodendrocytes and the green signal 
is representing oligodendrocytes. The second row from top is related to images from mouse line which expressing 
YFP under control of Ng2 promoter (Ng2-Yfp) and the green color is showing oligodendrocyte precursor cells 
(OPCs). The third row is the images from mouse line with labeled microglia and the green signal is coming from 
GFP protein is expressed in Microglia under control of Cxcr promoter (Cxcr-Gfp). The last row of the images is 
related to Aldh1L1-Gfp (ALDG) mouse line with labeled astrocytes (green signal) (Scale bar: 50 µm, frame Size: 
200*150 µm). (B) Is showing the quantification of different cell type population (the ratio of GFP or YFP (each cell 
type) / the total number of cells (DAPI) in whole optic nerve section) after 24h incubation under normal (Glc) or 
starvation condition (Stv). (C)  Showing the survival of different cell types in the whole longitudinal section from 






live cells for each cell type after 24h starvation with the frequency of each cell type after 24h incubation under 
normal conditions. (8-9 weeks old, male or female, statistics: t-test, error bars: mean+/-SEM, n: ≥3).  
 
3.2.4. Why do astrocytes die in the absence of glucose? 
In order to see why astrocytes are dying, alternative conditions including low 
concentration of glucose or Beta-hydroxybutyrate were applied. Two possibilities for astrocyte 
death were assumed:  the lack of glucose that could be important for pentose phosphate 
pathway or the lack of available metabolites. Our data revealed both metabolites can support 




Figure 4. Presence of 1 mM glucose or 1.5 mM beta-hydroxybutyrate is enough for supporting the survival of optic 
nerve cells. 
(A) The images from longitudinal optic nerve sections (8-micron thick) of wild type mice after 24h incubation in 
the presence of aCSF + 1 mM glucose(left) or + 1.5 mM beta-hydroxybutyrate (right). The blue dots showing the 
nucleus of the cells were stained with DAPI and the red signal is PI that has been used for detecting cells death 
(Scale bar: 50 µm, frame Size: 200*150 µm). (B) Is showing the quantified cells death in the whole longitudinal 
section from the optic nerve expressed in percent (ratio of PI / DAPI) after 24h incubation. (Wild type mice, 8-9 
weeks old, male or female, statistics: t-test, error bars: mean+/-SEM, n:3).  
 
 
3.3. Myelin-derived fatty acuds as a source of energy under starvation conditions 
In the second section, evidence suggesting that FA metabolism and myelin degradation 
are involved in supporting the survival of optic nerve cells under starvation conditions will be 
presented. The results obtained from perturbing FA oxidation under starvation conditions by 





3.3.1. Effect of beta oxidation inhibitors on survival of optic nerve cells under starvation- 
proteomics study 
Perturbing beta-oxidation in starved nerves followed by protein expression studies 
suggests FAs support cell survival under starvation condition. Our previous data showed optic 
nerve cells survive for a long time (16h) in the absence of glucose (Fig.3), suggesting alternative 
sources of energy, such as FAs, to support cell survival. Under starvation conditions, there are 
two possible sources of glucose for the nerve: stored glycogen in astrocytes (Wender et al., 
2000) and products of gluconeogenesis. Since FA degradation depends on the presence of 
oxygen while glucose can produce ATP through glycolysis, to exclude the possible role of 
glucose in this long-term support, the nerves were incubated under hypoxia condition. Our 
data revealed that when glucose is available, majority of cells survive (around 85%) under 
hypoxic condition, whereas hypoxia induces massive cell death in incubated nerves under 
starvation conditions (Fig. 5A and B). These pieces of evidence support the possible role of FA 
degradation in ATP production.  
 
 
Figure 5. Hypoxia effect on survival of optic nerve cells incubated in aCSF+ 10 mM glucose (Glc) / or 10 mM sucrose 
(Stv) for 16h. 
(A) The images from longitudinal optic nerve sections (8-micron thick) of wild type mice after 16h incubation under 
hypoxic condition (by gassing the solution with 95% N2 + 5% CO2) in aCSF + 10 mM glucose (left) or + 10 mM 
sucrose (right).  The blue dots showing the nucleus of the cells were stained with DAPI and the red signal is PI that 
has been used for detecting cells death (Scale bar: 50 µm, frame Size: 200*150 µm). (B) Representing the 
quantified cells survival in the whole longitudinal section from the optic nerve expressed in percent (ratio of PI / 







Studies on isolated rat brain mitochondria had suggested 3-keto-acyl-CoA thiolase is the 
rate limiting enzyme for brain FA beta-oxidation (Yang et al., 1987) and 4-Bromocrotonic acid 
(4-Br) has been reported to be a specific inhibitor for this enzyme (Olowe and Schulz, 1982). 
To investigate whether FA degradation is involved in supporting the survival of nerve cells 
under starvation conditions, the nerves were incubated in aCSF+ 10 mM glucose or sucrose in 
the presence of 25 µM, 4-Br for 16h and were stained with PI. Our results revealed that 
inhibiting mitochondrial beta-oxidation under starvation conditions induces massive cell death 
while the presence of glucose renders the inhibitor ineffective (Fig 6A and B). These 
observations clearly show that the inhibitor is not toxic to the cells and that FAs and their 
derivatives are catabolized in glial cells for ATP production under starvation conditions. 
 
 
Figure 6. Effect of mitochondrial beta-oxidation inhibition on survival of optic nerve cells incubated in aCSF+ 10 mM 
glucose (Glc) / or 10 mM sucrose (Stv) for 16h. 
(A) The images from longitudinal optic nerve sections (8-micron thick) of wild type mice after 16h incubation in 
aCSF + 10 mM glucose(left) or + 10 mM sucrose (right) in the presence of 25 µM 4-bromocrotonic acid (4-Br), 
specific inhibitor for mitochondrial beta-oxidation and ketolysis.  The blue dots showing the nucleus of the cells 
were stained with DAPI and the red signal is PI that has been used for detecting cell death (Scale bar: 50 µm, frame 
Size: 200*150 µm). (B) Representing the quantified cell survival in the whole longitudinal section from the optic 
nerve expressed in percent (ratio of PI / DAPI) after 16h incubation. (Wild type mice, 8-9 weeks old, male or female, 
statistics: t-test, error bars: mean+/-SEM, n:3).  
 
 
It is generally believed there is an interaction between peroxisomes and mitochondria, 
and that peroxisomes provide metabolites to mitochondria for degradation and ATP 
production. To see if peroxisomal beta-oxidation inhibition affects survival of optic nerve cells, 





mechanism of action for thioridazine is unknown, it has been accepted as a specific inhibitor 
for peroxisomal beta-oxidation (Van den Branden and Roels, 1985) and there has not been any 
reports on its effects on mitochondrial beta-oxidation until now. The obtained data from 
incubated nerves in the presence of 5µM thioridazine did not affect viability of cells either 
under normal or under starvation conditions (fig. 7A and B). These observations suggest that 
inhibiting beta-oxidation in peroxisomes does not result in a drop in ATP production in 
mitochondria below the minimum level needed for cell survival. 
 
 
Figure 7. Effect of peroxisomal beta-oxidation inhibition on survival of optic nerve cells incubated in aCSF + 10 mM 
glucose (Glc)/ or 10 mM sucrose (Stv) for 16h. 
(A) The images from longitudinal optic nerve sections (8-micron thick) of wild type mice after 16h incubation in 
aCSF + 10 mM glucose (left) or + 10 mM sucrose (right) in the presence of 5 µM Thioridazine (Thio), specific 
inhibitor for peroxisomal beta-oxidation. The blue dots showing the nucleus of the cells were stained with DAPI 
and the red signal is PI that has been used for detecting cell death (Scale bar: 50 µm, frame Size: 200*150 µm). (B) 
Representing the quantified cell survival in the whole longitudinal section from the optic nerve expressed in 
percent (ratio of PI / DAPI) after 16h incubation. (Wild type mice, 8-9 weeks old, male or female, statistics: t-test, 
error bars: mean+/-SEM, n:3).  
 
 
In order to see if there is a change in expression of proteins involved in metabolism, 
proteomic analysis was performed. Thanks to the MPI-EM proteomics facility, Dr. Olaf Jahn and 
Doerte Hesse for analyzing the samples. Autophagy is induced by glucose deprivation, 
therefore we expected to see regulation of gene involved in this process. Since it has been 
reported that ATP is needed for autophagy (Plomp et al., 1987), a low level of glucose was 
applied as a starvation condition in this experiment. In the previous section, the nerve 






Therefore, the optic nerves from 2-month-old wild type mice were incubated for 24h in the 
presence of 10 mM glucose as the normal condition and 1 mM of glucose as the starvation 
condition. The analyzed data revealed a change in expression of several genes involved in 
glucose uptake and utilization, autophagy, lipid metabolism, and FA transport. In general, these 
results imply that 1) glucose uptake has increased and glucose utilization has decreased, 2) 





Figure 8. Effect of 16h starvation on protein expression profile of optic nerve cells (incubated in aCSF+ 10 mM 
glucose (Glc)/ or 1 mM glucose (Stv)). 
(A) Silver stained gel of optic nerve lysate after 24h incubation in aCSF+ 10 mM glucose (Glc) / or 1 mM glucose 
(Stv). (B) Showing the changes in protein expression of optic nerve cells after 16h incubation in aCSF + 1 mM 
glucose (Starvation) in comparison with aCSF+10 mM glucose. The purple circles are showing proteins involved in 
beta-oxidation of FAs and their intracellular trafficking. The red circles are showing proteins involved in glucose 
utilization and the orange ones are proteins involved in autophagy. (Wild type mice, 8-9 weeks old, male or female, 
statistics: t-test, error bars: mean+/-SEM, n:5 biological replicate and 2 technical replicates).  
 
 
3.3.2. Effect of starvation on myelin thickness (ex vivo) 
It is known that ketone bodies produced in the liver as derivatives of FAs support brain 
metabolism during starvation. However, it has not yet been shown in ex vivo experiments and 
thus raised the question where FAs has been stored. Considering the fact that oligodendrocytes 
have a long survival capacity starvation conditions (Fig. 3) and that myelin is rich in FA, we 





mouse optic nerve under starvation condition. To verify our hypothesis, the optic nerves from 
wild type mice at two months of age were incubated in aCSF+ 10 mM glucose /or sucrose for 
16h and subjected to electron microscopy. Thanks to Dr. Weibke Möbius, Torben Ruhwedel 
and Boguslawa Sadowski in the electron microscopy (EM) facility in MPI-EM for imaging the 
samples. The provided images by the EM facility were used for g-ratio quantification as a 
readout for myelin thickness. Although the average g-ratio of starved nerves was not 
significantly different (data not shown), the number of axons with a thinner myelin (g-ratio 
between 0.8-1) has significantly increased in the absence of glucose (Fig. 9A-C). This 




Figure 9. Effect of 16h starvation (aCSF + 10 mM sucrose (Stv)) on thickness of myelin in acutely isolated optic nerve. 
(A) Micrographs obtained from cross sections of mouse optic nerve after 16h incubation under normal (aCSF + 10 
mM glucose, upper image) and starvation condition (aCSF + 10 mM sucrose, lower image) (scale bar: 2000 nm). 
(B) showing the calculated g-ratio for obtained images by dividing the diameter of outer layer of myelin to the 





the nerves after 16h incubation under normal (aCSF+10 mM glucose) and starvation condition (aCSF+ 10 mM 
sucrose). (Wild type mice, 8-9 weeks old, male or female, statistics: t-test, error bars: mean+/-SEM, n:3).  
 
3.4. Role of fatty acid metabolism in supporting nerve function under starvation condition 
In this section of the results, ex vivo electrophysiology of optic nerve and monitoring of 
ATP levels in axons were performed to investigate the effect of FA metabolism under starvation 
conditions on mouse optic nerve function. In the previous two sections of the results, the role 
of FA metabolism on the survival of optic nerve cells was studied. As we observed in the 
previous section, nerve cells can stay alive for long in the absence of glucose (Fig. 2). However, 
the energy that is needed for the nerve to exert its function is much higher than the level 
needed for cells to survive. Indeed, it has been reported that the nerve function declines shortly 
( ̴ 15min) after switching to aglycemic condition (Brown et al., 2003; Trevisiol et al., 2017). 
Therefore, it is necessary to find the starvation condition for recording the nerve function. The 
term starvation (or threshold) condition in electrophysiology experiments in this project is 
referred to a combination of glucose concentration and frequency of stimulation in which the 
optic nerve is still functioning while it is under metabolic stress.  
Briefly, the optic nerve of the mouse is clamped with suction electrodes and the nerve is 
electrically stimulated from one end and the signal is recorded using recording electrodes at 
the other end. The recorded signal has three peaks related to different groups of axons with 
different signal propagation speeds. Since the signal results from the function of all the axons 
in the nerve, it is called compound action potential (CAP) and the area under the signal is 
referred to CAP area. By recording the nerve function during an experiment and plotting the 
calculated CAP area for every single trace over time it is possible to monitor the changes in 
nerve function during an experiment. in the next step, the calculated area could be normalized 
to the baseline condition, the optimal condition for nerve function. Using the optic nerve from 
mice that genetically encode a FRET sensor for ATP in their neurons (Trevisiol et al., 2017), we 







3.4.1. Finding the threshold condition for optic nerve function 
A three-step protocol was designed such that the first two steps were common among all 
recording protocols unless otherwise stated. It has been reported the glycogen content of the 
optic nerve after 2h incubation is equilibrated to extracellular glucose concentration (Brown et 
al., 2003), in order to make sure the glycogen content of the nerve is equally adjusted to the 
available glucose, the baseline was recorded always in aCSF+10 mM glucose for 2h as the first 
step of protocol. The protocol was followed by 5min aglycaemia, to partially remove the stored 
glycogen. Since glycogen depletion results in an insult to rat optic nerve (Wender et al., 2000), 
the recording was continued in aCSF+10 mM glucose (third step of the protocol) to see if nerve 
function declines because of such damage. The recorded data in the presence of 10mM 
glucose revealed 5-min glycogen depletion does not affect the nerve function adversely. It 
should also be noted that since the signal was stable in the presence of 10 mM glucose, this 
can exclude technical influence on data obtained (Fig. 10A).  
To find the threshold condition, the third step of the protocol was replaced by different 
concentrations of glucose (instead of 10 mM glucose) including 2-, 2.7-, 3-, 3.3- and 3.7-mM 
glucose. Our data revealed the nerve function for concentrations of glucose above 2.7 mM 
glucose during the ̴ 6.5h recording is not significantly different from optimal condition (10mM 
glucose). In addition, 2mM glucose was not sufficient for the nerve function and the CAP was 
declining much faster in comparison to higher glucose concentrations (Fig. 10A and B). 
Therefore, concentrations between 2.7 mM and 3.3 mM could be used as threshold 







Figure 10. Optic nerve function at different concentrations of glucose obtained by ex vivo electrophysiology using 
suction electrodes to find the lowest glucose concentration needed nerve function. 
(A) The compound action potential area (CAP area) has been calculated for every single trace during the 
experiment and plotted over time and for each condition average of calculated CAP area has been represented. 
Function of the nerve has been recorded at different concentrations of glucose including 10, 3.7, 3.3, 3, 2.7 and 2 
mM that the related CAP area has been depicted in curves with gray, green, light blue, dark blue, light brown and 
dark brown colors respectively. (B) Showing the calculated area under the obtained curves in (A) for each glucose 
concentration (selected time window: 2h:5min till end). (Wild type mice, 8-9 weeks old, male or female, statistics: 
statistical significance in comparison with 10 mM glucose, t-test, error bars: mean+/-SEM, n ≥3)  
 
To find the threshold condition for stimulation frequency, the nerve function was recorded in 
aCSF+3.3 mM glucose and different frequencies were applied for nerve stimulation. The 
recorded nerve function stimulated with frequencies between 0.033 – 1 Hz showed when 
frequencies higher than 0.066 Hz is applied for stimulation, the CAP decline significantly faster 
in comparison to 0.033 Hz (Fig. 11 A and B).  
Using the data obtained from mouse optic nerve recordings at different glucose concentrations 
and different frequencies (Fig. 10 and Fig. 11), a protocol was designed to investigate the role 
of FA metabolism in nerve function under starvation conditions by applying specific inhibitors. 
This protocol also includes three steps, the first two steps were 2h baseline recording (aCSF+10 
mM glucose, 0.033 Hz), and 5min aglyceamia (aCSF+ 0 mM glucose, 0.033 Hz) respectively. The 
third step was recording in low concentrations of glucose (2.7 mM +/- inhibitor) and a RAMP 
protocol composed of 0.2 Hz (for 2.5h), 1 Hz (54 min), 3 Hz (30 min) and 7 Hz (30 min) for 










(A) The compound action potential area (CAP area) has been calculated for every single trace during the 
experiment and plotted over time and for each condition average of calculated CAP area has been represented. 
Function of the nerve has been recorded in aCSF+ 3.3 mM glucose at different frequencies including 0.033-, 0.04-
, 0.05-, 0.066-, 0.1, 0.2 and 1 Hz that the related CAP area has been depicted in curves gray, green, purple, orange, 
blue, yellow and red colors respectively. (B) Showing the calculated area under the obtained curves in (A) for each 
frequency (selected time window: 2h:5min till end,). (Wild type mice, 8-9 weeks old, male or female, statistics: t-
test, statistical significance in comparison with 0.033 Hz, error bars: mean+/-SEM, n ≥5)  
 
 
3.4.2. Beta-hydroxybutyrate supports nerve function under starvation condition 
It is well known that ketone bodies can be metabolized by brain cells during starvation. 
However, electrophysiological recordings have failed to show that ketone bodies are utilized 
for supporting nerve function (Brown et al., 2001). To see if ketone bodies are being used by 
brain, we applied beta-hydroxybutyrate in combination with 3.3 mM glucose. Our data 
revealed beta-hydroxybutyrate (10 mM) alone is not able to maintain nerve function; however, 
in combination with glucose (3.3 mM glucose + 6.7 mM beta-hydroxybutyrate) it improves the 
nerve function significantly (Fig. 12A and B).  
 
 
Figure 12. Support of optic nerve function by beta-hydroxybutyrate (HB) alone and in combination with glucose. 
(A) Representing the optic nerve function (compound action potential (CAP area))of wild type mice recorded after 
baseline (2h, 10 mM glucose, 0.033 Hz) and partial glycogen depletion (5 min, 0 mM glucose, 0.033 Hz) at low 
concentration of glucose (gray curve: 3.3 mM, Frequency of stimulation 0.2 Hz),  in the presence of beta-
hydroxybutyrate (blue curve: 10 mM, Frequency of stimulation 0.2 Hz) and in the presence of beta-
hydroxybutyrate in combination with glucose (in green: 3.3 mM glucose + 6.7 mM beta-hydroxybutyrate (HB), 





window: 2h:5min till end) in (A) for each condition. (Wild type mice, 8-9 weeks old, male or female, statistics: data 
were normalized to the average of 3.3 mM glucose), t-test, error bars: mean+/-SEM, n ≥3). 
3.4.3. Effect of blocking mitochondrial beta-oxidation on nerve function under starvation 
conditions 
Recording the optic nerve function under starvation conditions revealed that the CAP 
area declines faster when mitochondrial beta-oxidation is inhibited by applying 25 µM 4-Br 
(Fig. 13 A and B). At the same time by monitoring ATP level in axons, a direct correlation 
between ATP level and CAP decline was observed (Fig. 13C and D). These data for the first time 
clearly show that beta-oxidation of endogenous FA sources in the nerve are involved in 
supporting nerve function when glucose is not sufficient to meet energy demands. In order to 
normalize the ATP level in the axons, the RAMP protocol was followed by applying Azide in the 
absence of glucose (to block mitochondrial beta oxidation and deplete ATP in axons). In 
addition, a decreased recovery was observed in treated nerves with 4-Br in comparison with 
control after reperfusion with aCSF+10 mM glucose (Fig. 13E and F). To exclude the role of 
inhibitor toxicity in the observed decline, the nerve function was recorded in aCSF+10 mM 
glucose in the presence of 25 µM 4-Br. Since the CAP is not affected by the inhibitor when the 
glucose level is high (10 mM) (Fig. 13G and H), it was concluded that CAP decline under 







Figure 13. Effect of mitochondrial beta-oxidation inhibitor (25 µM 4-Br) on optic nerve function under starvation 
obtained by ex vivo electrophysiology using suction electrodes. 
(A) Representing the optic nerve function (compound action potential (CAP area)) of THYATPA mouse line 





Hz) at low concentration of glucose (2.7 mM, RAMP stimulation: 0.2, 1, 3 and 7 Hz) in the absence (gray curve) 
and presence (purple curve) of 25 µM mitochondrial beta-oxidation inhibitor, 4-Bromocrotonic acid (4-Br) (n ≥5). 
(B) Showing the average of CAP area for the traces have been recorded during the last 5 min of each step of RAMP 
protocol (0.033 (baseline), 0.2, 1, 3 and 7 Hz). (C) Showing the changes in ATP level in axons of the same optic 
nerves that their CAP area has been shown in (A). The changes in ATP level was monitored using a genetically 
encoded FRET sensor in neurons (Protocol: solutions and frequency of stimulation was the same as (A)) in the 
presence (purple curve) and absence (gray) of 4-Bromocrotonic acid (4-Br). The curve is showing the FRET signal 
normalized to CFP and plotted over time (n ≥4). (D) Showing the quantifications of the ATP level during the last 5 
min of each step of RAMP protocol (FRET/CFP). (E) Representing the effect of 5 mM Azide (aCSF+10 mM sucrose) 
on nerve function and nerve function recovery after reperfusion with aCSF+ 10 mM glucose (n ≥5). (F) Showing 
the quantification related to nerve recovery in section (E) (CAP area after recovery / mean of CAP area obtained 
during the last 5 min of RAMP protocol). (G) Showing the calculated CAP area recorded from optic nerve of wild 
type mice in aCSF + 10 mM glucose in the presence (red curve) and absence (gray curve) of 25 µM 4-Bromocrotonic 
acid (4-Br). The applied frequency for stimulating the nerve was 0.033 Hz (n ≥5). (H) representing the calculated 
area under the obtained curves (selected time window: 2h: 5min till end) in (G). (8-9 weeks old mice, male or 
female, statistics: t-test, error bars: mean+/-SEM, n ≥5).  
 
To see if beta-oxidation of long chain FAs in the mitochondria is involved in supporting 
nerve function under starvation conditions, nerve function was recorded in the presence of 
specific inhibitor for degradation of LCFAs, Etomoxir (Etox). Our data revealed that the CAP 
declines faster under starvation condition when 5 µM Etox is applied (Fig.14A and B). 
Combining electrophysiology with ATP level monitoring in axons, our data revealed a faster 
decline in the CAP that is accompanied with a faster decline in axonal ATP (Fig. 14C and D). 
These observations clearly show that degradation of LCFAs in nerve cells is involved in 
supporting the nerve function under starvation. In order to normalize the ATP level in the axons, 
the RAMP recording was followed by ATP depletion using Azide in the absence of glucose. 
After nerve reperfusion with aCSF+10 mM glucose, we did not observe significant differences 
in nerve function recovery of Etox-treated samples compared to the control (Fig. 13E and F). 
To rule out the observed decline is caused by toxicity of the inhibitor, the nerve function was 
recorded under optimal condition (aCSF+10 mM glucose) in the presence of inhibitor, Etox. 
The CAP area did not show any decline in the presence of inhibitor and 10 mM glucose (Fig. 









Figure 14. Effect of long chain FA beta-oxidation inhibition (5 µM Etomoxir) on optic nerve function under starvation 
obtained by ex vivo electrophysiology using suction electrodes. 
(A) Representing the optic nerve function (compound action potential (CAP area))of THYATPA mouse line recorded 





low concentration of glucose (2.7 mM, RAMP stimulation: 0.2, 1, 3 and 7 Hz) in the absence (gray curve) and 
presence (blue curve)of  5 µM of long chain FA beta-oxidation inhibitor, Etomoxir (Etox)( n ≥6). (B) Showing the 
average of CAP area for the traces have been recorded during the last 5 min of each step of RAMP protocol (0.033 
(baseline), 0.2, 1, 3 and 7 Hz). (C) Representing the changes in ATP level in axons of the same optic nerves that 
their CAP area has been shown in (A). The changes in ATP level was monitored using a genetically encoded FRET 
sensor in neurons (Protocol: solutions and frequency of stimulation was the same as (A)) in the presence (blue 
curve) and absence (gray) of Etomoxir (Etox). The curve is showing the FRET signal normalized to CFP and plotted 
over time (n ≥3). (D) Showing the quantified ATP level during the last 5 min of each step of RAMP protocol 
(FRET/CFP). (E) Representing the effect of 5 mM Azide (aCSF+10 mM sucrose) on nerve function and nerve 
function recovery after reperfusion with aCSF+ 10 mM glucose (n:6). (F) Showing the quantifications related to 
nerve recovery after Azide treatment (CAP area after recovery was normalized to the mean of CAP area obtained 
during the last 5 min of RAMP protocol). (G) Showing the calculated CAP area recorded from optic nerve of wild 
type mice in aCSF + 10 mM glucose in the presence (red curve) and absence (gray curve) of 5 µM Etomoxir (Etox). 
The applied frequency for stimulating the nerve was 0.033 Hz (n ≥4). (H) representing the calculated area under 
the obtained curves (selected time window: 2h: 5min till end) in (G). (8-9 weeks old mice, male or female, statistics: 
t-test, error bars: mean+/-SEM).  
 
3.4.4. Effect of blocking peroxisomal beta-oxidation on nerve function under starvation 
condition (Thioridazine and Mfp2 KO mice) 
Peroxisomal beta-oxidation provides some metabolites to mitochondria for degradation. 
To see if peroxisomes are involved in supporting nerve function under starvation condition, the 
CAP (8-9 weeks old wild type mice) was recorded under starvation condition in the presence 
of 5 µM Thioridazine (Thio), the specific inhibitor for peroxisomal beta-oxidation. Peroxisomal 
beta-oxidation inhibition resulted in a faster decrease in nerve function (Fig. 15A and B) 
compared to the control and a similar decline was observed in axonal ATP of the nerve (Fig. 
15C and D). These data for the first time show the importance of peroxisomal beta-oxidation 
in optic nerve cells for nerve function under starvation. The recovery of the nerves after Azide 
treatment was not significantly different with respect to the control (Fig. 15E and F). The 
recorded CAP under optimal condition (10 mM glucose) and in the presence of inhibitor does 
not show a decline in nerve function (Fig. 15G and H), implying that the inhibitor is not toxic to 









Figure 15. Effect of peroxisomal beta-oxidation inhibition using (5 µM Thioridazine) on optic nerve function under 
starvation obtained by ex vivo electrophysiology using suction electrodes. 
(A) Representing the optic nerve function (compound action potential (CAP area)) of THYATPA mouse line 
recorded after baseline (2h, 10 mM glucose, 0.033 Hz) and partial glycogen depletion (5min, 0mM glucose, 30-1 





and presence (brown curve) of 5 µM of long chain FA beta-oxidation inhibitor, Thioridazine (Thio)(n ≥5). (B) 
Showing the average of CAP area for the traces have been recorded during the last 5 min of each step of RAMP 
protocol (0.033 (baseline), 0.2, 1, 3 and 7 Hz). (C) Representing the changes in ATP level in axons of the same optic 
nerves that their CAP area has been shown in (A). The changes in ATP level was monitored using a genetically 
encoded FRET sensor in neurons (Protocol: solutions and frequency of stimulation was the same as (A)) in the 
presence (brown curve) and absence (gray) of Thioridazine (Thio). The curve is showing the FRET signal normalized 
to CFP and plotted over time (n ≥5). (D) Showing the quantified ATP level during the last 5 min of each frequency 
of RAMP protocol (FRET/CFP). (E) Representing the effect of 5 mM Azide (aCSF+10 mM sucrose) on nerve function 
and nerve function recovery after reperfusion with aCSF+ 10 mM glucose (n ≥5). (F) Quantifications related to 
nerve recovery after Azide treatment (CAP area after recovery normalized to the mean of CAP area obtained 
during the last 5 min of RAMP protocol). (G) Showing the calculated CAP area recorded from optic nerve of wild 
type mice in aCSF + 10 mM glucose in the presence (red curve) and absence (gray curve) of 5 µM Thioridazine 
(Thio). The applied frequency for stimulating the nerve was 0.033 Hz (n ≥4). (H) Representing the calculated area 
under the obtained curves (selected time window: 2h: 5min till end) in (G). (8-9 weeks old mice, male or female, 
statistics: ttest, error bars: mean+/-SEM).  
 
By applying thioridazine, peroxisomal beta-oxidation is inhibited in all cells of the nerve 
universally. To investigate the role of oligodendrocyte peroxisomes in supporting nerve 
function under starvation condition, the optic nerve from KO mice (MFP2fl/fl * Cnp-Cre+/-) with 
perturbed peroxisomal beta-oxidation were subjected to ex vivo electrophysiology. Our data 
revealed, the nerve function decreases faster in MFP2 KO mice compared to the control under 
starvation conditions (Fig. 16A and B). These data for the first time show the importance of 




Figure 16. Effect of perturbing peroxisomal beta-oxidation in oligodendrocytes (Mfp2 fl/fl * Cnp-Cre+/-) on optic nerve 
function under starvation obtained by ex vivo electrophysiology using suction electrodes. 
(A) Representing the optic nerve function (compound action potential (CAP area)) of Mfp2 KO mouse line 
(knockout (KO) and control (CTR) has been represented in pink and gray curves respectively) recorded after 
baseline (2h, 10mM glucose, 0.033 Hz) and partial glycogen depletion (5min, 0mM glucose, 0.033 Hz) at low 
concentration of glucose (3.3 mM, Stimulation frequency: 0.2 Hz). (B) Showing the mean of CAP area recorded the 
last 5 min of each steps of RAMP protocol. (8-9 weeks old mice, male or female, statistics: t-test, error bars: 





3.5. Mechanism of myelin degradation (autophagy perturbation: Tfeb KO mice, Lys05) 
and transport of fatty acids (Octn3 KO mice) 
Using pharmacology and transgenic mice we investigated the effect of perturbing 
autophagy and carnitine transport in peroxisomes (OCTN3) on optic nerve function. Our data 
revealed that the ablation of TFEB as a master regulator of autophagy in oligodendrocytes does 
not affect the nerve function under starvation conditions at frequencies below 3Hz. When a 
7Hz frequency was applied in the presence of 2.7mM glucose the CAP slightly declined faster 
in Tfeb KO mice in comparison with controls, however, it was not statistically significant (Fig17. 
A and B). To see if other signaling pathways are involved in autophagy regulation in the 
absence of TFEB, 5 µM of autophagy inhibitor was applied during the nerve recording of wild-
type mice under starvations. Our data revealed a significant improvement in treated nerves at 
frequencies lower than 1Hz, while this significant improvement disappears when 3 and 7Hz 
were applied for stimulation the nerve (Fig. 17A and B). Lys05 in nerve cells by applying Lys05 
improved the nerve function when 0.2 and 1Hz were applied however at higher frequencies. 
Since it has been reported that OCTN3 is involved in peroxisomal FA metabolism the 
optic nerve from the Octn3fl/fl * Cnp-Cre mouse line was subjected to ex-vivo electrophysiology. 
Our data revealed that the inactivation of OCTN3 in oligodendrocytes does not affect the nerve 








Figure 17. Effect of perturbing autophagy ((Tfeb fl/fl * Cnp-Cre+/-) and pharmacologically (Lys05)) and carnitine 
transporter in the membrane of oligodendrocyte peroxisomes on optic nerve function under starvation. 
(A) Representing the nerve function (CAP area) of optic nerve from Tfeb KO mouse line stimulated with different 
frequencies under starvation condition. (B) Showing the quantified CAP area (average of last 5min of each 
frequency) presented in (A). (C) Representing the recorded CAP area from optic nerve of wild type mice stimulated 
with RAMP protocol under starvation condition (2.7mM glucose) in the presence of autophagy inhibitor, Lys05 (5 
µM). (D) Showing the quantified CAP area (average of CAP area recorded in last 5min of each frequency) for 
presented data in (C). (E) Showing the optic nerve function of Octn3*Cnp-Cre mouse line (KO in red and CTR in 
gray) recorded in the presence of 3.3mM glucose (stimulation frequency: 0.2 Hz). (F) Representing the quantified 
CAP area at time point 7h (arrow head) presented in E. (t-test analysis was performed for all time point and the 
differences were not statistically significant). (8-9 weeks old mice, male or female, statistics: t-test, error bars: 








3.6. Effect of glucose uptake perturbation (in vivo) in mature oligodendrocytes on myelin 
thickness 
3.6.1. Confirmation of Glut1 ablation in oligodendrocytes 
In order to study the effect of starvation on myelin thickness under in vivo condition, the 
Glut1 fl/fl * Plp1-CreERT2+/- (ciKO) was generated and Tamoxifen injection was performed after 
myelination was complete at around two months of age. Upon performing Western blot on 
myelin preparations from brains after around four months post tamoxifen injection, we verified 
the successful knock out of Glut1 in oligodendrocytes and no significant change in expression 
of GLUT3 and MCT1 was observed compared to the control (Fig. 18A-D). Thanks to Dr. Aiman 
Saab and Zoe Loser from Zurich for providing us with the samples and Dr. Kathrin Kusch in our 




Figure 18. Immunoblotting results for myelin fraction obtained from Glut1 ciKO mice brain verifying ablation of 
GLUT1 transporter in oligodendrocytes. 
(A) The immunoblots for GLUT1, GLUT3, MCT1, α-tubulin (TUBA) and carbonic anhydrase2 (CA2) (TUBA and CA2 
as loading controls). (B-D) quantification of GLUT1, GLUT3 and MCT1 abundance calculated by normalizing signal 
intensities (obtained from images recorded by the near-infrared fluorescence imager) to their corresponding total 
protein quantified by fast green staining and the obtained normalized data (fluorescent signal intensity/ fast green 
intensity) were normalized again to the mean of values calculated for control mice.  (Animals: Glut1 CiKO mice 
four months post Tamoxifen injection, male or female, statistics: t-test, error bars: mean+/-SEM, n: 4). 
 
 
3.6.2. EM studies and g-ratio quantification in optic nerve of Glut1 ciKO mice 
After verifying the knocking out of the Glut1 gene in oligodendrocytes, the fixed optic 
nerves were subjected to electron microscopy. Thanks to our EM facility (Dr. Weibke Möbius, 





provided images revealed the g-Ratio has increase in ciKO mice (Fig. 19A - C), implying that 
myelin has degraded when glucose uptake is perturbed in mature oligodendrocytes. In 
addition, our data revealed the inner tongue size is not significantly different in ciKO in 

































Figure 19. G-ratio quantifications for optic nerves of Glut1 ciKO mice. 
(A) Electron micrographs from cross sections of the optic nerve of Glut1 ciKO mice (left and right images are 
corresponding to control (CTR) and knockout (KO) mice respectively). (B)  calculated g-ratio (Axon (ax)Ø/ outer 
layer (ol) of myelin Ø) and their distribution in CTR and KO mice. (C) Depicting the average of g-ratio calculated for 





(in gray) calculated by dividing (Axon (ax)Ø/ inner layer (il) of myelin Ø).  (E) Representing the average of inner 
tongue calculated for each nerve and presented as one data point in the bar graph.  (animals: Glut1 mice four 
























4.1. Susceptibility of different optic nerve cell types to starvation condition 
The main source of energy for the brain is glucose. However, the role of FAs in brain energy 
metabolism has been frequently neglected. Studies in rats have suggested that the beta-
oxidation of LCFAs takes place in the brain (Vignais et al., 1958) and using labeled octanoate 
and MRI has been estimated that FAs provide around 20% of the energy demand of the brain 
(Ebert et al., 2003). By employing primary cell culture from the developing rat brain it has been 
shown that neurons, oligodendrocytes, and astrocytes are able to utilize ketone bodies directly 
and that astrocytes are the only cells capable of degrading FAs (Edmond et al., 1987). It still 
remains unclear whether other cell types in the brain are able to oxidize FAs. 
Incubation of acutely isolated MON from wild-type mice of 8-9 weeks of age, showed that the 
optic nerve cells can survive starvation for a long time (16h) however, astrocytes were found to 
be the most vulnerable cells during prolonged glucose deprivation periods (24h). In addition, 
applying mitochondrial beta-oxidation suggests that FAs are being used by the nerve cells 
under glucose shortage. Why are astrocytes dying? Among some plausible causes we can 
identify 1) the lack of metabolites 2) Ros formation 3) other glucose functions (e.g. pentose 
phosphate path). It has been shown that astrocytes are capable of producing ketone bodies 
trough ketogenesis (Auestad et al., 1991) and It has been suggested that under pathological 
condition myelin-derived FAs are transported into astrocytes and are converted to ketone 
bodies that support neurons (Klosinski et al., 2015). Despite this novel finding, it cannot be 
concluded whether the myelin-derived FAs are passed to and used by other cells to survive or 
whether astrocytes are releasing ketone bodies upon FA oxidation to support axons and other 
nerve cells under starvation condition. However, due to the fact that astrocytes are dying prior 
to other cells types, and other cells are still alive, it does not seem that astrocytes involve in 
degradation of myelin-derived FAs and releasing metabolites (such as ketone bodies) to 
support other cell types in the nerve. Therefore, these observations suggest that other cells in 
the nerve are able to oxidize FAs in the absence of astrocytes. The discrepancy between our 
observations with the primary cell culture results (Auestad et al., 1991). could be because of 
two reasons: 1) the cultured cells were obtained from immature animals and cultured cells are 
not 100% comparable with mature cells in-vivo condition, 2) many cell-cell interactions 







Furthermore, we could show applying 1 mM glucose or 1.5 mM beta-hydroxybutyrate rescue 
the death of astrocytes suggesting that lack of glucose that is needed for example for pentose 
phosphate pathway (PPP) could not be the cause of astrocytes death, rather it is suggesting 
probably FAs are not transported to astrocytes, since beta-hydroxybutyrate as a lipid derivative 
could support the survival of the astrocytes. This contradiction with the suggested mechanism 
by Klosinski et al (Klosinski et al., 2015) might be explained by considering other sources of FA 
available for astrocyte in their experiment. In our starvation experiments, the incubated nerves 
(ex vivo) did not have access to external sources of FAs since no FA was supplemented to aCSF 
and the nerve was not perfused by the blood supply, contrary to in vivo condition. In addition, 
recently it has been reported that neurons produce peroxidated-FA, following high neuronal 
activity and ROS production. These peroxidated-FAs are transported to astrocytes via ApoE-
positive lipid particles for degradation (Ioannou et al., 2019). Therefore, the observed increase 
in FA metabolism in astrocytes could also be related to the degradation of the ApoE positive 
lipid particles. 
To unravel the transport of FAs to astrocytes for ketogenesis purposes, further studies need to 
be considered. Because of the lack of a specific inhibitor for ketolysis, the use of transgenic 
mice (e.g. [SCOT]) should be considered. Moreover, because beta-hydroxybutyrate has been 
reported to play other roles other than metabolic fuel, including antioxidant properties and 
cellular signaling (Haces et al., 2008; Newman and Verdin, 2017), the addition of exogenous 
FAs would simulate the in vivo situation. Since there is evidence regarding the role of gap 
junctions in the transport of metabolites, applying blockers for gap junctions would also be an 
important experimental approach to consider in expanding our knowledge of the FA transport 
between cells in nervous system. 
 
4.2. Fatty acids are metabolized by optic nerve cells under starvation condition 
Mitochondria and peroxisomes are involved in the degradation of FAs and the interaction 
between these two organelles has been suggested (Baes and Van Veldhoven, 2012; Violante 
et al., 2013; Longo et al., 2016; Tracey et al., 2018) Inhibiting mitochondrial beta-oxidation and 
ketolysis resulted in the death of nerve cells under our experimental conditions (aCSF + 10 mM 
glucose /or sucrose + 4-Br; Fig. 6). However, the inhibition of peroxisomal beta-oxidation that 
in turn provides mitochondria with metabolic substrates, does not affect the viability of the 






oxidation of VLCFAs is restricted to peroxisomes while other types of FAs are substrate for both 
organelles we can hypothesize a compensation for lack of peroxisomal beta-oxidation by 
mitochondria. 
Our proteomics data suggest a shift in glucose metabolism into FA degradation during 
starvation. For example, there is a tendency in overexpression of hexokinase -I and II, involved 
in the uptake of glucose by the cell along with a down-regulation of PFKAM, the rate-limiting 
enzyme for glycolysis. Implying that glucose uptake and utilization for ATP production has 
increased and decreased respectively. These changes are accompanied by an alteration in the 
expression of several genes involved in FA transport and oxidation in the nerve cells. Acyl-CoA 
dehydrogenase, ACAD9, that plays a role in the assembly of complex I in mitochondria, apart 
from its dehydrogenase activity on long-chain acyl-CoA (Schiff et al., 2015) has been 
significantly upregulated under starvation. Crotonase, another mitochondrial enzyme involved 
in beta-oxidation of FAs, shows a tendency for being upregulated under starvation. Among 
enzymes involved in peroxisomal beta-oxidation, we have observed that one of the isoforms 
of thiolase (Acaa1a) has been significantly down-regulated however, the other isoform 
(Acaa1b) shows a tendency for overexpression. Since the substrate-specificity for these 2 
enzymes is not well known we cannot conclude whether one isoform compensates for the 
other or, whether a switch between substrate utilization has taken place. FABP3 has been 
reported to have a direct effect on the oxidation of exogenous FAs in brown adipose tissue 
(Vergnes et al., 2011). Based on the Ben Barres RNA Seq database 
(https://www.brainrnaseq.org/) this protein is expected to be highly expressed in neurons and 
in contrast, its lowest level of expression is expected in astrocytes. On the other hand, FABP7 
with the expectation of having its highest expression in astrocytes (Ben Barres RNA seq 
database) has been significantly down-regulated during starvation: this appears to be in line 
with the conclusion that astrocytes do not seem to be receiving myelin-derived FA. In addition, 
in line with the fact that autophagy is induced under the condition of starvation (Glick et al., 
2010), we reported the overexpression (or a tendency) of several proteins involved in 







4.3. Beta-oxidation in both mitochondria and peroxisomes is involved in supporting 
nerve function when glucose availability is restricted  
FAs are involved in brain energy metabolism and astrocytes are considered as the only cell type 
capable of using FAs to produce ketone bodies. It is still a matter of debate whether 1) other 
cells of the brain, e.g. neurons, are able to utilize FAs 2) FA metabolism plays an important role 
in neuronal function (Schönfeld and Reiser, 2013; Panov et al., 2014;  Schönfeld and Reiser, 
2017). By combining ex vivo electrophysiology of young adult MON (8-9 weeks old) with 
confocal microscopy to measure axonal ATP via a genetically encoded ATP sensor, we provided 
evidence for the role of FA metabolism in neuronal function. Our data revealed that when 
mitochondrial beta-oxidation of FAs (and ketone bodies) is inhibited, the nerve function 
declines faster in comparison to untreated nerve and this decline is correlated with similar 
changes in axonal ATP level. Similar results were obtained when mitochondrial beta-oxidation 
of long-chain FAs was inhibited. Here we are providing clear evidence that the optic nerve, 
intended as a model for white matter tracts is capable of oxidizing FAs, as concluded via 
previous observations reported by Ebert et al., that estimated up to 20% of the total brain 
energy in rats is provided by FAs (Ebert et al., 2003). However, we should be aware that in our 
experiment the nerve is solely using endogenous sources of FAs stored in the nerve cells. In 
contrast to our observation, provided data using isolated brain mitochondria and astrocytes 
from rats supplemented with octanoic acid it has been concluded that the brain is not using 
FAs (Schönfeld and Reiser, 2017). The reasons the authors could not detect beta-oxidation are 
very likely because of a lack of glucose in their incubation buffer since it has been reported 
that FAs can be oxidized only in the presence of carbohydrates (Panov et al., 2014) or lack of 
cell-cell interactions. In agreement with the fact that FAs can be oxidized only in the presence 
of carbohydrates, we have observed in our experiments that beta-hydroxybutyrate, used as a 
lipid derivative can only support nerve function when glucose is available (Fig. 12), while it is 
well known that ketone bodies can be metabolized by the brain during starvation or during 
the suckling period (Owen et al., 1967; Cahill, 2006; Klosinski et al., 2015). These observations 
are supported by the physiological concentration of blood glucose that, even during long 
starvation periods never reaches zero (Jeremy M Berg, John L Tymoczko, 2002).  
Applying beta-oxidation inhibitors under normal conditions (aCSF+10mM glucose) did not 
have an impact on the nerve function, implying that the inhibitor is not toxic to the nerve. In 
addition, this observation might suggest that FAs do not play a role in supporting nerve 
function when glucose is available (in agreement with Schönfeld finding). This data should be 






glucose uptake and utilization in myocytes and prostate cancer cells (Abdel-aleem et al., 1994; 
Schlaepfer et al., 2015) though we do not know if the same increase in glucose uptake is to be 
expected in nerve cells. Therefore, it is speculated that an increased glucose metabolism in 
nerves where beta-oxidation is inhibited might be a compensation for the lack of beta-
oxidation itself.  
Another organelle involved in the degradation of FAs is peroxisome. Following the inhibition 
of peroxisomal beta-oxidation by applying pharmacology, we observed a faster decline in the 
compound action potential of treated nerve in comparison to control. Again, similar to 
mitochondrial beta-oxidation, the inhibition of peroxisomal beta-oxidation affected the ATP 
level in the axons. This observation is in contrast with our data obtained from optic nerve 
incubation experiment showing that peroxisomal beta-oxidation inhibition does not induce 
cell death under starvation. This discrepancy in our observation can be explained by 
considering the energy demand differences under starvation, between housekeeping activities 
and the function of the nerves. In our incubation experiment, we revealed optic nerve cells can 
survive for long time (16h) in the absence of glucose while based on electrophysiology 
recordings the nerve cannot maintain its function (under the same condition) for more than 15 
min during which stored glycogen in astrocytes can still support the nerve function (Brown et 
al., 2003). Suggesting that peroxisomal beta-oxidation becomes essential when energy 
demand is higher. The recorded nerve function under normal condition vs. in the presence of 
peroxisomal beta-oxidation inhibition excludes a toxic effect of the inhibitor and shows that 
the observed decline under starvation is rather energy-dependent. 
 
4.4. Beta-oxidation in myelin peroxisomes play an important role in supporting optic 
nerve function under starvation 
By ectopically applying specific drugs, beta-oxidation can be inhibited, however this is a global 
effect that affects all cells. By using conditional KO mice (Mfp2fl/fl * Cnp-Cre+/-) we could observe 
an important role for peroxisomes in oligodendrocytes in supporting nerve function, under 
metabolic stress. The Mfp2fl/fl * Cnp-Cre+/- mice have perturbed peroxisomal beta-oxidation 
specifically in oligodendrocytes and also in myelin processes: this line has been previously 
described by Verheijden et al. and the authors reported no phenotype or obvious abnormality 
in myelin structure, at least in mice younger than 12 months. The implication is that 






Therefore, the observed decline during our experimental paradigm cannot be explained by 
pre-existing damage to the nerve given that our experimental mice were very young (8-9 weeks 
old). 
The obtained data from nerve conduction recording clearly shows that FA beta-oxidation, both 
in peroxisomes and mitochondria, are involved in supporting nerve function under 
metabolically challenging conditions. However, which cells are degrading FAs remains unclear. 
There are two possible scenarios for the fate of FAs in white matter tracts exposed to starvation: 
1) FAs can be used/preferred by glial cells under starvation for ATP production: the 
consequence of this is the saving of glucose (or derivatives) that can be transported directly to 
neurons for supporting the nerve function 2) FAs (or derivatives) are transported directly into 
axons for complete degradation to CO2 and ATP production in axonal mitochondria. The results 
obtained from the nerve incubation in the absence of glucose suggests that FAs (derivatives) 
are metabolized by glial cells under starvation. For verifying the second scenario, i.e. the 
oxidation of FAs and derivatives directly by axonal mitochondria should be further clarified. It 
is well accepted that lipid-derived ketone bodies can support the brain function: using rat brain 
neuronal culture it has been shown that neurons can, in fact, oxidize ketone bodies (Edmond 
et al., 1987). Using isolated mitochondria from neurons it has been reported that palmitate 
could be fully oxidized by axonal mitochondria to CO2 (Panov et al., 2014). On the other hand, 
the long-chain FA are considered uncoupling agents (Takeuchi et al., 1991) and can also affect 
the electron transport chain in mitochondria, resulting in the production of reactive oxygen 
species (Cocco et al., 1999; Loskovich et al., 2005; Schönfeld and Wojtczak, 2007). Therefore, 
beta-oxidation of FAs in neuronal mitochondria can lead to the generation of reactive oxygen 
species, particularly harmful to neurons. In addition, beta-oxidation of FA consumes a higher 
amount of oxygen in comparison to glucose (or its derivatives): this increases the risk of a 
hypoxic condition for neurons. Because of the mentioned side effects of FA utilization for ATP 
production, the brain “prefers” glucose over FA as a primary source of energy (Schönfeld and 
Reiser, 2013). Moreover, the expression of carnitine palmitoyl transferase (CPT1a and CPT1b), 
necessary for the uptake of long-chain FA by mitochondria, is very low in neurons and restricts 
beta-oxidation to long-chain FA in neurons (Cahoy et al., 2008; Lee and Wolfgang, 2012). It 
should be noted that CPT1c is expressed specifically in neurons and plays an important role in 
energy homeostasis, however, its enzymatic activity is yet not clear and it does not support FA 
oxidation (Wolfgang, 2016) (Roa-Mansergas et al., 2018). Considering the interaction between 






explainable: peroxisomes are accumulated in the paranodal regions, the active zone of axon-
myelin interaction (Kassmann, 2014). These paranodal peroxisomes do not seem to be trapped 
during myelin compaction since their presence has been reported in cytoplasmic channels, 
stretches of oligodendrocyte’s cytoplasm that connect with the paranodal loops (Kassmann et 
al., 2011) Therefore, it is speculated that the presence of myelin peroxisomes near axonal 
mitochondria should serve some metabolic function (Kassmann, 2014). Since our 
electrophysiology data shows myelin peroxisomal beta-oxidation is involved in supporting 
nerve function, it suggests peroxisomes providing metabolites to axonal mitochondria. 
Considering that one of the aims for beta-oxidation is the chain shortening of FAs, the end 
products, medium and short-chain FAs, e.g. propionyl-CoA (Wanders et al., 2016), acetyl- CoA, 
acetate, and acetoacetyl-CoA (Hovik et al., 1991) are very likely transported into axonal 
mitochondria for ATP production. Since these metabolites are shortened in their FA carbon-
backbone, they do not result in uncoupling of the ETC in the inner mitochondrial membrane 
(Schönfeld and Wojtczak, 2016). In addition, medium and short-chain FA do not need FABP for 
their intracellular trafficking and their import into mitochondria is independent of the carnitine 
palmitoyl-transferase system (CPT1a and b). These possible explanations are supported by 
evidence of an accumulation of lipid droplets in glial cells observed in a CPT2- knockout in 
drosophila. CPT2 rescue only in glial cells was sufficient for the degradation of these lipid 
droplets and it is suggested that the produced ketone bodies are then used for energy 
production (Schulz et al., 2015). These results lead to the conclusion that when glucose 
concentration is transiently low, e.g. under starvation, the oxygen demand for the degradation 
of FA is temporarily elevated, without detrimental effects on neurons.  
In conclusion, the interaction between myelin and axonal mitochondria, preserved in ex-vivo 
and in-vivo preparations, seems to make the degradation of FA (derivatives) by neurons 
logically possible (such interaction is missed in cell culture experiments) and further 
investigations using KO mice with neuron-specific perturbation of lipid and ketone body 
metabolism is required to define which type of FA derivatives are used possibly by neurons. 
 
4.5. Investigation on mechanism of myelin degradation and export of peroxisomal 
beta-oxidation products 
Autophagy is induced under starvation to provide metabolites for energy production and TFEB 






Based on RNA-seq data, this transcription factor is expressed in myelinating oligodendrocytes 
as well (https://www.brainrnaseq.org/). In order to see if autophagy is induced in 
oligodendrocytes to release myelin-derived FAs for beta-oxidation, optic nerves from Tfeb KO 
mice were subjected to electrophysiology. However, the nerve function was not significantly 
different between CTR and KO mice. These observations suggest that TFEB does not play an 
important role in releasing FAs in oligodendrocytes under starvation conditions. However, it 
does not exclude the role of autophagy in myelin digestion. It has been reported recently that 
the expression of lysosomal and autophagy genes and the number of LAMP1-positive puncta 
in Tfeb KO mice (ablated in oligodendrocytes (Tfebfl/fl * Cnp-Cre+/-) have not been altered in 
comparison with CTR.  A recent study suggests other autophagy regulators such as TFE3 might 
function redundantly or cooperatively with TFEB (Sun et al., 2018). Since other autophagy 
regulators might compensate for lack of TFEB, it seems that the necessary machinery for 
autophagy is still present in oligodendrocytes even in the absence of TFEB. This might explain 
why the nerve function is not affected in Tfeb KO mice under starvation conditions. On the 
other hand, applying autophagy inhibitors suggest that autophagy is not involved in myelin 
degradation. This discrepancy might be due to the insufficient dose of inhibitor applied to 
block autophagy. Therefore, these findings remain inconclusive at this stage and further 
experiments should be done for unraveling the underlying mechanism of myelin degradation. 
   It has been reported that OCTN3 might be involved in the export of beta-oxidation products 
from peroxisomes (Januszewicz et al., 2009). To see if OCTN3 plays important role in axonal 
support by myelin peroxisomes, OCTN3 was ablated specifically in oligodendrocytes (Octn3fl/fl 
* Cnp-Cre+/-) and recording of the nerve function was performed. Our data did not show any 
significant difference between nerve function of CTR and KO mice under starvation conditions 
suggesting either OCTN3 is not involved in supporting nerve function or that OCTN3 functions 
with other possible transporters cooperatively or redundantly. Another possibility is that the 
end products of peroxisomal beta oxidation are not exported in carnitylated form. Since the 
mechanism of metabolite transport across peroxisomal membrane is largely unknown, this 
remains unanswered and further investigation is needed for unraveling the mechanism of 








4.6. Myelin: a source of energy when glucose is limited  
As opposed to prolonged starvation, under a “fed condition” the organism’s adipose tissue can 
store lipids within a single, large lipid droplet that can occupy the cell cytoplasm almost entirely 
(Nishimoto and Tamori, 2017). This lipid structures have been described in the brain of 
unmyelinated species like Lamprey (Weil et al., 2018) and evidence for their role in axon-glia 
metabolic coupling has been provided in drosophila in a study that speculated a possible role 
for FA metabolism in aging and Alzheimer disease (Schulz et al., 2015). However, until now 
there is no report on the presence of lipid droplets in oligodendrocytes. To study the effect of 
starvation on myelin in vivo we employed a Glut1 ciKO (Glut1fl/fl * Plp1-CreERT2+/-). Glucose 
uptake via Glut1 is therefore perturbed in post-myelinating oligodendrocytes and the 
measured g-ratio as a readout for myelin thickness showed a decrease in myelin thickness in 
the optic nerves [19]. This observation implies that myelin-derived FAs can be degraded under 
a shortage of glucose. Importantly, although the myelin was found to be thinner in knock-out 
mice at four months post tamoxifen injection, the animals did not show any obvious 
phenotype, or neuroinflammation. However, at present, we cannot exclude the possibility of 
neurodegeneration shortly after tamoxifen injection. The lack of phenotype in Glut1fl/fl * Plp1-
CreERT2+/- mice with thinner myelin is unexpected since myelin thickness is important for the 
conduction velocity of action potential propagation and consequently affects the neuronal 
signal processing. Similar results were obtained by incubating acutely isolated wild-type optic 
nerves under glucose deprivation. Altogether these observations suggest a new function for 
myelin, as an energy reservoir: a function similar to the lipid droplets as a store of energy during 
metabolic stress and substrate shortage. The maintenance of a close-to-normal brain function 
while a thinner myelin is present can be explained by changes in nodal length as a mechanism 
that has been predicted by modelling to be energy saving (Arancibia-Cárcamo et al., 2017). 
Our observations supported by several studies showing changes in white matter (under specific 
conditions).  In anorexia nervosa, a severe mental disorder in which energy intake is restricted 
persistently leading to a significant body weight loss, alterations in white matter microstructure 
of the corpus callosum and possible myelin loss have been described(Swayze et al., 2003) 
(Nickel et al., 2019). Along with these findings, it has been reported that during aging and 
Alzheimer's disease, a decrease in glucose uptake is accompanied by a metabolic shift toward 
FA oxidation where myelin is being degraded to fuel brain cells. However, in this study, myelin 
degradation was observed under pathological conditions and the authors could not conclude 
to which extent such myelin degradation can occur in the healthy brain. Taken together, we 






neurons when glucose availability is transiently (not persistent like pathological condition) scarce 
and might explain the importance of myelin in neurodegenerative diseases (Fig. 20). 
 
 
Figure 20. Interaction between myelin peroxisomes and mitochondria in degradation of myelin FA under starvation. 
Myelin-derived FAs are released under metabolic stress condition and depending on their chain length they could 
be directly degraded in mitochondria or after going through peroxisomal beta-oxidation, the beta oxidation 
products could be used for supporting neuronal function. The exact mechanism by which FAs are released and 









5. Material and methods 
5.1. Mouse lines 
All animals were breeded in the animal facility of the Max- Planck Institute for 
Experimental Medicine (MPI-EM) and were kept under a 12h day and night cycle with access 
to food and water ad libitum. All the experiments were carried out in compliance with approved 
animal policies of the MPI-EM. In this work the following mouse lines were used: 
 
5.1.1. ALDG mouse line (mixed background) 
The Aldh-GFP mouse line expresses GFP specifically in astrocytes. In this mouse line 
enhanced green fluorescent protein (EGFP) is expressed under aldehyde dehydrogenase 1 
family, member L1 (Aldh1l1). This mouse line was generated provided by Dr. Gesine Saher 
(http://www.informatics.jax.org/allele/MGI:3843271). The background of this mouse line was 
originally Swiss albino and the animals were cross breeded with C57Bl6 mice and resulting 
offspring with mixed background were used in our experiments. 
 
5.1.2. Cxcr-GFP mouse line (C57BL6 background) 
This mouse line was present in the animal facility of MPI-EM expresses GFP under a Cxcr 
promoter and specifically labels microglia (Jung et al., 2000). 
  
5.1.3. mEos2 mouse line (C57BL6 background) 
 The mEos2 mouse line has labeled oligodendrocyte. In this mouse line the mEos2 (Cnp-
mEos2-PTS1) is expressed under Cnp1 promoter and because of the presence of targeting 
signal sequence for peroxisomes (PTS1), this fluorophore is transported into peroxisomes of 









5.1.4. Ng2-YFP mouse line (C57BL6 background) 
The Ng2-YFP mice express yellow fluorescent protein under the NG2 promoter such that 
oligodendrocyte precursor cells (OPCs) are labeled specifically (Karram et al., 2008). This mouse 
line was used for distinguishing oligodendrocyte precursor cells from other cell populations in 
the mouse optic nerve. 
 
5.1.5. Mfp2 mouse line (C57BL6 background) 
Mfp2 fl/fl transgenic mice generously provided by Prof. Myriam Baes (Verheijden et al., 
2013), were cross breed with Cnp-Cre mouse line (Lappe-Siefke et al., 2003)  to generate 
conditional knock out mice (Mfp2 fl/fl * Cnp-Cre+/-) (Thanks to Sarah Richert) with perturbed 
peroxisomal beta-oxidation in oligodendrocytes. In this project, the optic nerve from this 
mouse line was used for studying the role of peroxisomal beta-oxidation in supporting nerve 
function under starvation condition.  
 
5.1.6. Glut1 mouse line (C57BL6 background) 
Glut1 fl/fl mice was a generous gift from Prof. E. Dale Abel (Iowa university) has been 
described previously (Young et al., 2011). In order to generate ciKO mice, they were cross breed 
with Plp1-CreERT2 mice (Leone et al., 2003) in the animal facility of MPI-EM.  The generated 




In order to exclude the developmental effects of lack of GLUT1 protein in 
oligodendrocytes, the animals were injected with Tamoxifen at two months of age, when 
myelination is complete. Recombination of Glut1 in oligodendrocytes in ciKO animals was 
induced by injecting mice with Tamoxifen. Tamoxifen (Sigma Aldrich) was dissolved in corn oil 
at 10mg/ml concentration. At around two months of age, when myelination is complete, the 





animals were injected intraperitoneally (IP) with a dose of 100mg/kg bodyweight/day of 
Tamoxifen for five consecutive days and the tissues were collected four months after injection. 
 
5.1.7. Tfeb mouse line (C57BL6 background) 
Previously described transgenic Tfebfl/fl mice were generously provided by Prof. Andrea 
Blabio (Settembre et al., 2012). This mouse line was cross breed with Cnp-Cre mouse line 
(Lappe-Siefke et al., 2003) and the conditional knock out mice (Tfebfl/fl * Cnp-Cre+/-) were 
generated in the animal facility of Max Planck Institute for Experimental Medicine. 
 
5.1.8. Octn3 mouse line (C57BL6 background) 
To generate Octn3 conditional knockout mice, the sperm of Octn3fl/fl mice 
(Slc22a21tm1a(KOMP)Wtsi )  was ordered from KOMP. The ordered sperms were used for IVF to 
generating Octn3loxP/wt mice. Generated Octn3 fl/fl mice were cross breeded with Cnp-Cre mouse 
line (Lappe-Siefke et al., 2003) to specifically knock out OCTN3 in oligodendrocytes. Generated 
KO mice (Octn3 fl/fl * Cnp-Cre+/-) were used in this project. 
 
5.1.8. THYATPA mouse line (C57BL6 background) 
In order to monitor ATP level in axons, the THYATPA mouse line with a genetically 
encoded ATP sensor was used. The animals generously were provided by Prof. Johannes 
Hirrlinger and Dr. Andrea Trevisiol. The mouse line as described previously, expresses ATP-













5.2. Genotyping  
5.2.1 DNA extraction 
The Nexttec™ Tissue & Cells kit was used for DNA extraction from ear or tail biopsies for 
genotyping the animals via PCR. DNA preparation was performed according to the 
manufacturer’s protocol. Biopsies were digested in 300µl of lysis buffer (265 μl buffer G1, 10 μl 
buffer G2, 25 μl buffer G3) by shaking for 1-2h at 62 °C. The columns were prepared by 
equilibrating the NexttecTM cleanPlate96 with 350 μl Prep buffer for 5 min at TR and 
centrifugation for 1 min at 350 g. In next step, 120 μl of the lysates were loaded onto 
equilibrated columns and after 3min incubation at RT, the DNA was collected into fresh tubes 
by 1 min centrifugation at 750 g. In final step, the DNA obtained from tail and ear biopsies 
were diluted to 1:8 and 1:3 respectively and used for genotyping.   
 
5.2.2. PCR reaction 
Polymerase chain reaction (PCR) is used for amplification of a DNA sequence of interest 
(template DNA) in vitro (Mullis et al., 1986). The PCR cycles composed of three steps including 
denaturation, annealing, and extension of the DNA template sequence. During denaturation 
step, because of the high temperature the template DNA and primers (short sequences of DNA 
with around 18-30bp that are complementary to specific sequences of the gene of interest) are 
in single stranded form. In the second step, by lowering the temperature, the primers bind to 
the template DNA and provides the free 3’ end for acting a thermostable DNA polymerase, 
Taq polymerase. In last step, the polymerase synthesizes the DNA of interest by incubation at 
around 72°C, the optimal temperature for Taq polymerase activity. Repeating this three-step 












5.2.3. TAE buffer for gel electrophoresis 
50 x Tris-acetate EDTA (TAE) Buffer: 
 




Fill up to 1l with ddH2O 
 
5.2.4. Agarose gel electrophoresis 
The PCR products were separated on 2% agarose in TAE buffer (W/V). Briefly, agarose 
was added to TAE (1x) buffer and heated till agarose was completely dissolved. The prepared 
agarose solution was poured into a gel casting chamber with placed combs in appropriate 
distances. After gel formation (1-2 h at RT), the combs were removed gently and created wells 
were used for loading the PCR products. The gel was transferred into an electrophoresis 
chamber filled with TAE buffer (1x) and the mixed PCR products with GelRed (1:5 from stock 
1:4000) were loaded. In order to estimate the size of the products, an appropriate DNA marker 
was also loaded next to samples. By applying appropriate voltage, the negatively charged DNA 
fragments start to move toward the positively charged electrode and being separated based 
on their size.  In final step, the separated fragments of DNA were visualized under UV light. 
 
5.2.5. Genotyping primers and PCR protocols 
All the genotyping primers listed below were synthesized at the ‘DNA core facility’ of the 
Max-Planck Institute of Experimental Medicine and the following protocols were applied for 
performing PCR:  
 
 
50 mM  EDTA 
2.0 M  Tris-acetate, pH: 
8.0 
57.1 ml  glacial acid 





Aldg genotyping PCR:                        
Primers for Aldg 
Sense primer: 5'-CCCTTTCTAACCCTCTGGC -3' 
Antisense primer: 5'-TCCTTGAAGAAGATGGTGCG -3'   
        
                  PCR master mix for GoTaq polymerase                                     PCR program 
   
   
  
Cxcr-Gfp genotyping PCR: 
Primers for Cxcr-Gfp 
Sense primer: 5'-TCAGTGTTTTCTCCCGCTTGC -3' 
Sense primer: 5'-GTAGTGGTTGTCGGGCAGCAG -3'        
Antisense primer: 5'-CAGTGATGCTCTTGGGCTTCC -3' 
 
                     PCR master mix for GoTaq polymerase                                      PCR program 
          
                                                                       
95°C 3 min 
51°C            30 sec 
72°C          40 sec     x34 
95°C 15 sec 
50°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.10 μl sense primer (50 pM) 
0.10 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.15 μl GoTaq polymerase (5 U/μl) 
12.65 μl ddH2O 
95°C  3 min 
50°C 30 sec 
72°C            1 min      x34 
95°C 30 sec 
50°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.1 μl sense primer (50 pM) 
0.05 μl sense primer (50 pM) 
0.15 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.1 μl GoTaq polymerase (1 U/μl) 
12.6 μl ddH2O 





mEos2 genotyping PCR: 
Primers for mEos2 
Sense primer: 5'- CTTCTTACACAGGCCACCATGAGTGCG-3'   
Antisense primer: 5'-GGATCCTTACTTAGTTAAAGCTTGGATCGT-3'    
 
                     PCR master mix for GoTaq polymerase                                      PCR program 
             
    
 
Ng2-YFP genotyping PCR: 
Primers for Ng2-YFP 
Sense primer: 5'-CGCTGAACTTGTGGCCGTTTA -3' 
Sense primer: 5'-ACAGCTTTCCTTCCAGAC -3' 
Antisense primer: 5'-TGACCTTGGATTCTGAGC -3' 
 
                     PCR master mix for GoTaq polymerase                                      PCR program 
          
             
 
95°C 3 min 
60°C          30 sec 
72°C           1,5 min    x34 
95°C 30 sec 
50°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.10 μl sense primer (50 pM) 
0.10 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.15 μl GoTaq polymerase (5 U/μl) 
12.65 μl ddH2O 
95°C 3 min 
50°C 30 sec 
72°C            1 min      x34 
95°C 30 sec 
50°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.1 μl sense primer (50 pM) 
0.1 μl sense primer (50 pM) 
0.1 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.1 μl GoTaq polymerase(1U/μl) 
12.6 μl ddH2O 





Mfp2 genotyping PCR:          
Primers for Mfp2 
Sense primer: 5'-CCCAACGCTGGGTCACGGATGACGG-3' 
Antisense primer: 5'-GCAACCATAAGTTACACAAAATGCC-3'    
 
                      PCR master mix for GoTaq polymerase                                     PCR program 
          
             
                                                                         
Cnp-Cre genotyping PCR: 
Primers for Cnp-Cre 
Sense primer: 5'- GCCTTCAAACTGTCCATCTC-3'                                          
Sense primer: 5'- CATAGCCTGAAGAACGAGA-3'            
Antisense primer: 5'- CCCAGCCCTTTTATTACCAC-3'    
  
                PCR master mix for GoTaq polymerase                                       PCR program 
             
           
                                                                    
95°C 3 min 
65°C 1 min 
72°C            1 min      x35 
95°C 1 min 
60°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.10 μl sense primer (50 pM) 
0.10 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.1 μl GoTaq polymerase (1U/μl) 
12.7 μl ddH2O 
95°C 3 min 
50°C 30 sec 
72°C            1 min      x34 
95°C 30 sec 
50°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.1 μl sense primer (50 pM) 
0.05 μl sense primer (50 pM) 
0.15 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.1 μl GoTaq polymerase (1 U/μl) 
12.6 μl ddH2O 





Glut1 genotyping PCR: 
Primers for Glut1 
Sense primer: 5'-CTGTGAGTTCCTGAGACCCTG -3' 
Antisense primer: 5'-CCCAGGCAAGGAAGTAGTTC -3' 
 
                    PCR master mix for GoTaq polymerase                                        PCR program 
          
             
 
Pcet genotyping PCR:            
Primers for Pcet 
Sense primer: 5'-TGGACAGCTGGGACAAAGTAAGC -3' 
Antisense primer: 5'-CGTTGCATCGACCGGTAATGCAGGC -3' 
 
                   PCR master mix for GoTaq polymerase                                      PCR program 




95°C 3 min 
60°C 30 sec 
72°C            45 sec     x30 
95°C 30 sec 
60°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.10 μl sense primer (50 pM) 
0.10 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.1 μl GoTaq polymerase (1U/μl) 
12.7 μl ddH2O 
95°C 3 min 
60°C 30 sec 
72°C             45 sec     x30 
95°C 30 sec 
60°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.10 μl sense primer (50 pM) 
0.10 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.1 μl GoTaq polymerase (1U/μl) 
12.7 μl ddH2O 





Tfeb genotyping PCR: 
Primers for Tfeb 
Sense primer: 5'-GCTTGGGACACCCACAGCTCC -3' 
Antisense primer: 5'-GGACACCCCATAGAAAATCCG -3' 
 
                     PCR master mix for GoTaq polymerase                                    PCR program 
          
     
 
Octn3 genotyping PCR: 
Primers for Octn3 
Sense primer:  
Antisense primer:  
 
                 PCR master mix for GoTaq polymerase                                      PCR program 
             
           
                                                                    
  
95°C 3 min 
60°C 30 sec 
72°C           45 sec   x30 
95°C 30 sec 
60°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.10 μl sense primer (50 pM) 
0.10 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.1 μl GoTaq polymerase (1U/μl) 
12.7 μl ddH2O 
95°C 3 min 
60°C 30 sec 
72°C             45 sec      x30 
95°C 30 sec 
60°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.10 μl sense primer (50 pM) 
0.10 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.1 μl GoTaq polymerase (1U/μl) 
12.7 μl ddH2O 





ThyATPA genotyping PCR: 
Primers for ThyATPA 
Sense primer: 5'-TCTGAGTGGCAAAGGACCTTAGG-3' 
Antisense primer: 5'- CGCTGAACTTGTGGCCGTTTACG-3' 
 
                   PCR master mix for GoTaq polymerase                                       PCR program 
          
             
95°C 3 min 
60°C 30 sec 
72°C            30 sec     x35 
95°C 30 sec 
60°C 1 min 
72°C 10 min 
4°C pause 
1.00 μl DNA (100 pg-100 ng) 
0.10 μl sense primer (50 pM) 
0.10 μl antisense primer (50 pM) 
2.00 μl dNTP mix (2 mM) 
4.00 μl 5x GoTaq buffer 
0.1 μl GoTaq polymerase (1U/μl) 
12.7 μl ddH2O 





5.3. Solution (aCSF) for optic nerve incubation and recording 
First, Stock solutions A and B were prepared as following for long term storage at 4°C: 
 











In the following step, using the prepared stocks, the aCSF containing substrates were 
made. Briefly, an equal volume of stock A and B were mixed and were bubbled with Carbogen 
(95% O2, 5% CO2) in a water bath with adjusted temperature at 37°C. Glucose (or other 
substrates) was then added at a final concentration of 10 mM to the solution and the bubbling 
was continued for another 1-2 h. At the end CaCl2 (final concentration of 2 mM) was added 
and after a few minutes of bubbling, the pH of the solution was measured to ensure that it is 
in the normal range (pH: 7.4 – 7.48). In order to maintain the osmolarity constant among 
solutions prepared for different conditions, 10 mM of substrate was considered as standard 
and whenever concentrations lower than 10 mM glucose (or other substrates: beta-
hydroxybutyrate) was applied, the rest up to 10 mM was replaced by sucrose (Merck 
Millipore, Darmstadt, Germany), since it cannot be metabolized by the cells. The prepared aCSF 
containing in mM: 126 NaCl, 26 NaHCO3, 3 KCl, 2 MgSO4, 1.25 NaH2PO4 and 2 CaCl2, 10 
substrates (or substrate + sucrose), xxx phenol red was used for optic nerve incubation or 
electrophysiology recording.  
  
Salt M.W. [final mM] at 2X (mM) For 2 l (g) 
NaCl 58.44 126 252 29.45 
KCl 74.56 3 6 0.89 
Phenol red     
Salt M.W. [final mM] at 2X (mM) For 2 l (g) 
NaH2PO4 137.99 1.25 2.5 0.69 
NaHCO3 84.01 26 52 8.74 
MgSO4 246.48 2 4 1.97 
Phenol red  0.0001 0.0001  





5.4. Mouse optic nerve incubation and treatment 
After cervical dislocation, the mice were decapitated and the head skin was opened 
longitudinally, the eyeball was detached from the surrounding tissue, and the top of the skull 
was removed. After cutting the brain along the coronal plane in the middle, the optic nerve 
was cut at chiasmata and it was removed by pulling the eyeball gently. The prepared nerves 
attached to the eyeball were transferred into a six-well plate (Fig. 21) containing around 10 ml 
of aCSF inside an incubator with adjusted temperature at 37°C (with/ without inhibitors + 
different metabolites) and another 90ml of ACSF was circulating during the incubation period. 
To provide oxygen to the nerve cells and maintain the pH of the solution constant during the 




Figure 21. Prepared mouse optic nerve attached to the eyeball for incubation experiments. 
showing an example of acutely isolated mouse optic nerve (wild-type) for incubation experiments  
 
In order to study the role FA on survival of the nerves during incubation, specific 
inhibitors for mitochondrial beta-oxidation, 4-Bromocrotonic acid (25 μM)( TCI, ≥98%), 
peroxisomal beta-oxidation, Thioridzine (5 μM) (Sigma Aldrich, ≥99% Germany) and 
mitochondrial beta-oxidation of long chain FA, Etomoxir (5 μM, Tocris) were added to aCSF 
right before starting the experiment. In order to block mitochondrial oxidative 
phosphorylation, 5 mM sodium azide (Merck Millipore) was supplemented to aCSF acontaining 
10- or 0-mM glucose. In this case, in order to compensate for sodium concentration, the used 
stock A solution for making aCSF contained 121 mM NaCl.  
In order to study the effect of hypoxia on survival of optic nerve cells during incubation, 
during the incubation time aCSF was constantly bubbling with nitrogen (95% N2, 5% CO2) 





instead of carbogen (95% O2, 5% CO2) and to minimize the diffusion of oxygen into aCSF from 
the air, the wells were partially covered with pieces of parafilm (Merck). 
 
5.5. Cell death studies 
5.5.1. PI staining and sectioning 
In order to detect the dead cells in the optic nerve, propidium iodide (PI) staining was 
performed. PI is an impermeable dye and cannot cross the plasma membrane of intact cells 
while it is able to enter the dead cells because of the change in membrane permeability. To 
stain the nerve cells with PI, the mouse optic nerves (MON) were treated with 11.97 µM PI 1h 
before the incubation times ended and nerves were washed for 10 min in 7ml ACSF. The stained 
nerves were fixed for 2h in 4% paraformaldehyde (4% PFA: NaH2PO4 (20mM), Na2HPO4 
(80mM), 4% paraformaldehyde) at 4°C. In next step, the nerves were detached from eyeball 
and frozen blocks of nerves were made in Tissue-Tek® O.C.TTM compound (SAKURA, poland) 
for cryosectioning (cryostat, Leica). The frozen blocks of the optic nerve were left in cryostate 
for at least 60min and 8μm thick longitudinal sections were collected on superfrost® Plus 
(Thermo Scientific) slides so that the sections on upper and lower part of the slides were related 
to the surface of the nerve and the sections in the middle were corresponding to the middle 
part of the nerve. The obtained sections were kept in the dark at -20ºC for other staining 
procedures. 
 
5.5.2. DAPI staining 
  In order to count the total number of cells on each section the DAPI staining was 
performed. DAPI is an intercalating dye that stains the nucleus of the cells. The staining starts 
with 5min washing the sections in PBS (In mM: 170 NaCl, 3.4 KCl, 4.0 Na2HPO4, 1.8 K2HPO4, 
pH: 7.2) and followed by 10 min incubation with 200 μl of DAPI solution in PBS (1:20000, stock: 
1mg/ml). In the last step, the slides were washed for 5min in PBS and subsequently dipped in 
distilled water before mounting with aquapolymountant (Polyscience Inc). During the staining 
procedure samples were protected from exposure to light until microscopy.  





5.5.3. Imaging  
All the images were taken with an inverted epiflourescent microscope (Zeiss Axio 
Observer Z1) with 20x objective with the same UV lamp intensity otherwise stated. The 
exposure time settings for the PI and DAPI channel were the same for all images for quantifying 
the dead cells. However, the exposure time for GFP or YFP channel for defining different cell 
types in the nerve was adjusted according to the strength of the signal in each transgenic line 
and it was kept constant for all the related images for each line. Two to three sections of each 
nerve were imaged and the resulting frames for each section were stitched using the 
microscope software to acquire the whole picture of each section for further quantifications. 
 
5.5.4. Cell death quantification 
In order to quantify the percent of dead cells for each cell type in the nerve, Fiji and Imaris 
softwares (version 8.1.2) were used. The obtained stitched images were opened in Fiji software 
to remove the margin, cut site and in case of crush, the crushed area of the nerve that contain 
dead cells unrelated to starvation conditions Subsequently, by using “plug in” option in Imaris, 
the opened images in Fijji were further quantified. After adjusting the threshold for each 
channel, the spots were created for each nucleus that has a diameter of around 3.22 μm. Since 
the dead cells have more PI dye intercalated in the DNA, sometimes the DAPI cannot be 
intercalated with enough efficiency. Therefore, the DAPI signal for the PI positive cells are 
weaker and the software does include them for quantification. To minimize the errors related 
to the signal, all the spots for each channel were double-checked and manually modified 
whenever necessary. In last step, the software calculated co-localizations between different 
channels and the data were exported as excel files for statistical analysis.   
 
5.6. Proteomics and expression analysis 
5.6.1. Protein extraction from optic nerve: 
In order to minimize the variability between the samples and genetic background, one 
nerve of each mouse was incubated under starvation condition and the other one under normal 





condition and the nerves from each two mice were pooled together for protein extraction. The 
nerves were collected after 24h incubation in aCSF+10 mM or 1 mM (starvation) glucose, 
transferred into microtubes, and kept at -80°Cfor further analysis. The collected nerves were 
homogenized in 70 μl of RIPA buffer (Tris Hcl (50 mM), Na-deoxycholate (0.5%), NaCl (150 
mM), SDS (0.1%), Triton X100 (1%), EDTA (1 mM) and complete protease inhibitor cocktail 
(Roche, Mannheim, Germany)) using ceramic beads in a Precellys homogenizer. The 
homogenization was performed three times and each time was composed of 3 x 10sec at 
6500rpm. The samples were kept on ice between each round of homogenization. The resulted 
lysates were transferred into 1.5 ml Eppendorf tubes and centrifugation was performed for five 
minutes at 13000 rpm at 4 °C. The obtained supernatant was gently removed and transferred 
into new tubes for further analysis and the pellets were kept at -80 °C. 
 
5.6.2. Protein concentration measurement 
Protein concentration in the collected supernatant was measured using the Lowry assay. 
The assay had two steps: in the first step, the copper ions react with peptide bonds in the 
protein under alkaline condition and in the second step, the Folin reagent is reduced into a 
colorful product by copper treated proteins (Lowry et al., 1951). The Bio Rad DC Protein Assay 
reagents were purchased (Bio Rad) and protein measurement was performed according to the 
manufacturer protocol. Briefly, 20 μl of reagent S was added to each ml of reagent A. 25 μl of 
reagent A (+S) was added for every sample to a 96 well plate (flat bottom). Then 5 μl of standard 
solution or sample were added and after adding 200 μl of reagent B to each well the plate was 
incubated at room temperature for 15 min. After reading the absorbance of the samples at 736 
nm (Eon microplate spectrophotometer, Biotek instruments), the protein concentration was 
calculated based on the standard curve. 
 
5.6.3. SDS-PAGE 
In order to evaluate the integrity of the samples for proteomics, proteins were separated 
by SDS-PAGE and the gel was subjected to silver staining.  The samples were added to loading 





buffer containing 5% beta-Mercaptoethanol and after 10 min incubation at 40°C with shaking 
(550 rpm) they were ready for loading on the gel. The desired amount of protein was loaded 
on a 12% polyacrylamide gel next to a pre-stained protein marker (ThermoScientific) and 
separation of proteins was performed in a runninsg tank (Biorad) filled with running buffer 
(Laemmli-buffer) by applying appropriate current (voltage: 120; current: 300 mA) for around 
60 min. At the end of electrophoresis, the obtained gel was used for silver staining or for 
immunoblotting.  
 
 5.6.4. Silver staining 
In order to evaluate the integrity of extracted proteins from incubated optic nerves for 
proteomics studies, 0.5 µg of the protein was separated on 12% gel by doing SDS-PAGE and 
was subjected to silver staining (Sørensen et al., 2002). In fixation step, the gel was incubated 
in gel fixing solution (containing 40% (v/v) Ethanol and 10% (v/v) Acetic acid in dd H2O) for at 
least 60 min (or overnight). After two times incubating the gel in 30% (v/v) Ethanol for 20 min, 
it was washed with dd H2O for another 20 min. In sensitization step, the gel was treated with 
sodium thiosulfate (797.7 μM, Merck) for 1 min and after washing it with ddH2O (3 x 20 sec) it 
was used for impregnation by incubating it in silver nitrate (11.77 mM) for 20 min. After short 
steps of washing in dd H2O (3 x 20 sec) the color was developed by adding sodium carbonate 
(283 μM) until a sufficient and detectable signal appears. The reaction was then stopped by 
washing the gel in 5% (v/v) acetic acid (2 x 10 min). The stained gel was washed in water and 
after imaging for long storage was kept in dd H2O at 4 °C. 
  
5.6.5. Brain myelin preparation 
Glut1fl/fl*PlpCreT2+/--mice and their corresponding Glut1fl/fl-control mice (without 
PlpCreT2+/-) were sacrificed at four months post induction of recombination by tamoxifen 
injection. A light weighted membrane fraction enriched in myelin was obtained from frozen 
half brains by sucrose density gradient centrifugation essentially as described (Erwig et al., 
2019). Briefly, after homogenizing the brains in 0.32 M sucrose solution containing protease 





(complete, Roche), a first fraction enriched in myelin was obtained by density gradient 
centrifugation on a 0.85 M sucrose cushion. After washing and two consecutive osmotic shocks, 
the final brain myelin fraction was purified by sucrose gradient centrifugation as before. The 
myelin fraction was washed and suspended in TBS buffer (137 mM NaCl, 20 mM Tris/HCl, pH 
7.4, 4°C) supplemented with protease inhibitors (complete, Roche). Protein concentration was 
determined using the DC Protein assay (Biorad) according to the manufacturer’s instructions 
as mentioned above. 
 
5.6.6. Western blotting 
For immunoblotting, the proteins were separated by doing SDS-PAGE as described 
above. After activating polyvinylidene difluoride membranes (Immobilon-FL PVDF, IPFL00010, 
Merck-Millipore) by incubation in methanol for 1 min, a sandwich of the gel, PVDF membrane 
and Whatman papers was prepared and proteins were blotted onto the PVDF membrane in a 
wet blotting chamber (Biorad) filled with transfer buffer (10% (v/v) methanol, 48 mM tris-base, 
39 mM glycine and 0.003% (w/v) SDS). For quantification of total protein, blots were stained 
by fast green (5 mg/L fast green, Sigma, in 6.7 % [v/v] acetic acid, 30 % [v/v] methanol) 
immediately after transfer for 5 min, washed twice for 30 sec in 6.7 % [v/v] acetic acid, 30 % 
[v/v] methanol and imaged using the 700 nm channel of a near-infrared scanned (Odyssey, 
Licor). Consecutively, blots were destained in 50 %[v/v] ethanol in TBS (150 mM NaCl, 10 mM 
Tris/HCl, pH 7.4) Blocking was performed with 5% [w/v] skim milk in TBST (150mM NaCl, 10mM 
Tris/HCl, pH 7.4, 0.5%[v/v] Tween 20) for 60 min at RT and subsequently the membrane was 
incubated with primary antibodies diluted in the same solution ((GLUT1 (1:1000, Berghoff et 
al., 2017), GLUT2 (1:1000, ab54460, abcam), GLUT3 (1:1000, ab191071, abcam), GLUT4 (1:1000, 
07-1404, Millipore), MCT1 (1:1000, Stumpf et al., 2019), carbonic anhydrase 2 (CA2, 1:1000, 
Ghandour et al., 1980) and α-tubulin (TUBA, 1:1000, T 5168, Sigma)) for 48h at 4°C. In the next 
step, after washing with TBST (3 x 15 min on the shaker), blots were incubated with near-
infrared fluorophore coupled to secondary antibodies diluted in 5 %[w/v] skim milk in TBST 
(1:10000, Mouse IgG (H&L) Antibody Dylight™ 680 Conjugated, 610-144-002; Rabbit IgG (H&L) 
Antibody DyLight™ 800 Conjugated, 611-145-002; Rockland), washed with TBST, finally TBS 





and detected using a near-infrared fluorescence scanner (Odyssey, Licor). For quantification of 
GLUT1, GLUT3 and MCT1, images obtained from the near-infrared fluorescence imager were 
analyzed using the Image Studio software (Licor). Signal intensities were normalized to their 
corresponding total protein load as quantified by fast green staining. Normalized signal 
intensities for GLUT1, GLUT3 and MCT1 obtained for myelin samples of Glut1fl/fl*PlpCreT2+/--




5.7. Studying myelin thickness 
5.7.1. Electron microscopy 
In order to study the ultrastructure of myelin, mouse optic nerves were subjected to 
electron microscopy. The animals were sacrificed by cervical dislocation and the freshly 
prepared optic nerves (or incubated nerves) were fixed in Karlsson and Schultz fixative (4 % 
formaldehyde, 2.5 % glutaraldehyde, 0.5 % NaCl, in phosphate buffer pH 7.4) overnight at 4 °C. 
The following program was used for embedding the samples using an automated device (EM-
TP, Leica). The fixed samples were washed in buffer and osmified. After washing the osmified 
samples with buffer they were subjected to dehydration steps using acetone, which was 
replaced by Epon. Epon was prepared by mixing 171.3 g Glycidether 100 (Serva, 21045), 115 g 
Dodecenyl succinic anhydride (Serva, 20755) and 89 g of Methyl nadic anhydride (Serva, 29452) 
using a magnetic stirrer for 10 min. After adding 6.5 ml of DMP-30 (Serva, 36975) and stirring 
for another 20 min, the solution was ready to use. The treated samples (with above mentioned 
program) were placed in prepared Epon and the blocks from the samples was formed by 
incubation at 60 °C, overnight. Sections with 50-60 nm thickness were prepared by cutting the 
Epon embedded tissues using a Leica Ultracut S ultramicrotome (Leica, Vienna, Austria) 
equipped with a diamond blade (Diatome Hist 45° and Ultra 45 °C). The sections were placed 
on a grid and imaged using a LEO EM 912AB electron microscope (Zeiss, Oberkochen, 
Germany) equipped with an on-axis 2048x2048-CCD-camera (TRS, Moorenweis, Germany).  
 






Solution Time Temprature 
buffer 3 x 10 min 4 °C 
2% OsO4 4h 4 °C 
buffer 3 x 10 min 4 °C 
30% Aceton 20 min RT 
50% Aceton 20 min RT 
70% Aceton 20 min RT 
90% Aceton 20 min RT 










Epon  4h RT 
 
Embedding, sectioning and transmission electron microscopy imaging were kindly 
performed by Dr. Weibke Möbius, Torben Ruhwedel, Boguslawa Sadowski, - Neurogenetics 
department, Max-Planck Institute for Experimental Medicine. 
 
5.7.2. G-ratio analysis 
The obtained EM images from optic nerve of GLUT1 ciKO mice were opened with the Fijji 
software. In order to unbiasedly select the axons for quantification, a grid composed of cubes 
with 4 μm2 area was created on each image and the axons that were hit by the cross were 
filtered with the following criteria for quantification: 1) it should be in cross section, 2) it has 
enough quality for quantification, 3) it is not too much stretched in shape (judged by eye). For 
each axon, three circles were made around it corresponding to the inner tongue and the outer 
layer of myelin. Whenever the structure of the myelin around one axon was not preserved 





evenly, the thickness of myelin in adjacent preserved area was used as a reference and circle 
was corrected accordingly. The obtained area of each circle was converted into diameter and 
the g-ratio was calculated based on diameter values (at least 100 axons/nerve was quantified). 
Quantification for incubated nerve for 24h was performed slightly different from GLUt1 ciKO 
mice and the quantifiable axons were selected for quantification instead of using grid. 
 
5.8. Mouse optic nerve electrophysiology and live imaging 
In order to monitor both neuronal function and ATP level in axons, electrophysiology of 
optic nerve using suction electrodes was combined with live imaging. The optic nerve from 
THYATPA mouse line (expressing a FRET sensor for ATP in their axons) was clamped using 
suction electrodes filled with aCSF containing 10 mM glucose as illustrated in Fig. 22. 
 
 
Figure 22. Showing a scheme of combined electrophysiology and confocal imaging for monitoring neuronal function 
and ATP level in optic nerve from mouse line expressing ATP sensor in their axons. 
The placed optic nerve (in pink) in a recording chamber continuously perfused with aCSF. The electrode on the 
left side (stim. Electrode) of the chamber inject a current into the nerve and on right side the signal is recorded 
using recording electrode (Rec. electrode). The obtained signal (left side, down) has three peaks related to axons 
with different speed of signal propagation. The area under the signal is representing the function of all axons in 
nerve and is called compound action potential area (CAP area). While the nerve is receiving electrical stimulation, 
the objective on top of the nerve acquiring images every ≈ 30 sec at three different channels (top, from left to 
right: FRET, YFP, CFP; frame size: 114.5 μm x 133.5 μm; scale bar: 20 μm). 





5.8.1. CAP Recording 
All the mice used for optic nerve electrophysiology were at the age of 8-9 week unless 
otherwise stated. After cervical dislocation and decapitation, the optic nerve was detached from 
the eyeball and after removing the top of the skull the brain was pulled out carefully and the 
nerve was cut at chiasmata. The prepared nerves were transferred into a recording chamber 
(Harvard Apparatus, Holliston, MA) with continuous perfusion with aCSF (containing in mM: 
126 NaCl, 26 NaHCO3, 3 KCl, 2 MgSO4, 1.25 NaH2PO4 and 2 CaCl2, 10 substrate). To maintain 
the temperature at 37 °C during the experiments, the chamber was equipped with a 
temperature controller (model TC-10, NPI electronic) connected to a temperature sensor (TS-
100-S; NPI electronic) inserted in the chamber in direct contact with aCSF. In order to provide 
oxygen to the nerve cells during recording and maintain the pH of aCSF constant, the aCSF 
was continuously bubbling with carbogen (95% O2, 5% CO2). The optimal stimulation and 
recording condition were ensured by back filling the suction electrodes (custom-made) with 
aCSF containing 10mM glucose in all experiments. To achieve supermaximal stimulation, the 
stimulating electrode connected to the battery (Stimulus Isolator 385; WPI, Berlin, Germany) 
was injecting a current of 0.75 mA magnitude into the proximal end of the optic nerve with 
each stimulation. The produced signal detected at the distal end of the nerve using recording 
electrode connected to the headstage (Heka Electronik, Germany), amplified 200 or 500 times 
and after filtering at 30 kHz (low noise amplifier, Stanford, USA) was acquired at 100 kHz with 
an EPC9 amplifier (Heka Elektronik, Lambrecht/Pfalz, Germany). Acquired signal was amplified 
further using Ext 10-2F amplifier (NPI electronic) and low-noise voltage preamplifier SR560 
(Stanford Research System) 10 times and 20-50 fold respectively (Stys et al., 1991; Saab et al., 
2016; Trevisiol et al., 2017).  
For making suction electrodes, glass capillaries (1.5 mm, #1B150-6, World Precision 
Instruments) were heated at one end on the flame and manually were bended to an angle that 
fits the recording chamber. Silver wires with 0.25 mm thickness (World Precision Instruments) 
were coated with chloride and at one end they were attached to the gold pin. In the stimulating 
electrode, one of the wires was inserted into the glass capillary and the other one was wrapped 
around it and the wires were connected to positive and negative poles of the battery. In the 





recording electrode composed of two capillaries, the wires were placed inside capillaries and 
were connected to the headstage. The glass parts and wires were sealed together using the 
heat-shrinking tubes and were attached to two arms equipped with two micromanipulators 
(Luigs & Neumann) for adjusting the positions of the electrodes on the recording chamber. All 
the recordings were done after nerve equilibration for 2h in aCSF containing 10mM glucose as 
baseline otherwise stated. During baseline recording the nerves were evoked every 30 sec and 




An upright confocal laser scanning microscope (Zeiss LSM 510 META/NLO, Zeiss, 
Oberkochen, Germany) equipped with an Argon laser and a 63x objective (Zeiss 63x IR-
Achroplan 0.9 W) was used for live imaging of the optic nerve. After putting the nerve into the 
suction electrodes, the objective gently immersed into the aCSF superfusing the optic nerve 
and images were acquired with a time resolution of around 30 sec. The imaging settings were 
adjusted as reported previously (Trevisiol et al., 2017). A frame size of ≈ 114.5 μm x 133.5 μm 
(384 x 448 pixels) was scanned for CFP (excitation 458 nm; emission 470–500 nm), FRET (Ex 458 
nm; Em long pass 530 nm) and YFP (Ex 514 nm; Em long pass 530 nm). 
 
5.8.3. CAP analysis 
Optic nerve function can be measured quantitatively by calculating the area under the 
signal that is representative of function of all nerve axons, referred as compound action 
potential (CAP) area. Optic nerves are a heterogeneous structure composed of a variety of 
axons with different rate of signal propagation. The obtained signal from the optic nerve 
includes three peaks that are representative of different axons with different rate of signal 
speed (Stys et al., 1991; Saab et al., 2016; Trevisiol et al., 2017). The signal related to the fastest 
group of axons is appeared in first peak and the second and third peaks are related to axons 
with medium and slow rates of signal propagation. To select the time window for calculating 
the CAP area, the start of the first peak and end of third peak of the recorded signal at the last 





few minutes of the baseline, when the signal is very stable, were defined. This time window was 
then applied to all the recorded traces for calculating the CAP area. After normalizing the data 
to the average of CAP area values obtained from the last 30 min of the baseline, the results 
from several nerves were pooled, averaged and plotted against time. In order to present the 
overall function of the nerve during a desired time window, the area under the CAP area curve 
was calculated and presented as area under the curve for each nerve after normalizing the 
values to the mean value of control nerves, bar graphs were plotted for them.  
 
5.8.4. ATP quantification 
The relative level of ATP was calculated as previously reported (Trevisiol et al., 2017). The 
images were opened in Fiji and the area of the nerve that was stable during the imaging were 
selected for measuring the mean intensity for three different channels: FRET, CFP and YFP. Then 
the ratio of FRET /CFP as relative ATP amount was calculated and normalized to zero and one 
by using the values obtained during the mitochondrial ATP blockade (5 mM Azide) and 
baseline (10 mM glucose) steps respectively. 
 
5.9. Data presentation  
All data are presented as mean ± SEM. for data regarding cell death measurements in the optic 
nerve, the data of at least two technical replicates were combined and the mean was 
considered as one data point. Therefore, N-number indicates biological replicates. The number 
of optic nerves analyzed for each condition is given as n. As in all experiments only one nerve 
of each mouse was included for each condition, the number of nerves is equal to the number 
of animals analyzed for each condition. However, there is an exception about samples for 
proteomics measurements that two nerves were pooled together. To see if there is a significant 
difference between different conditions, the data were statistically evaluated using Welch’s t-
test and normal distribution was assumed (*p<0.05; **p<0.01; ***p<0.001). Apart from the used 
Microsoft excel for data analysis, Microsoft Office and Adobe illustrator softwares were used 
for preparing figures and writing this thesis.  
  





5.10. MATLAB Script for CAP analysis  
The recorded signal in Patchmaster are saved as .dat files and after being exported as .mat files they 
were processed by the following script in MATLAB (written by Dr. Andrea Trevisiol).  
clear all; clc  
[FileName,PathName] = uigetfile('*.mat','Select the MATLAB code file');  
S = load(fullfile(PathName,FileName)); 
    prompt={'Enter value for signal amplification used: '}; 
    name = 'Amplification';  
    defaultans = {'200'}; 
    amplif = inputdlg(prompt,name,[1 40],defaultans); 
    Mag = sprintf('%s*', amplif{:});  
    Mag = sscanf(Mag, '%f*');  
fig1=figure('Name','CAP waveforms',... 
    'Color', [0.99 0.99 0.99],... 
    'Position', [380 180 1280 720],... 
    'Units', 'pixels'); 
for f = fieldnames(S)' 
    i = S.(f{1}); 
    u = horzcat((i(:,1)-i(1,1))*1.00e+3,i(:,2).*(1000/Mag));  
    plot(u(:,1),u(:,2)); 
    hold on; 
end 
title('CAP'); 
xlabel('time [ms]');  
ylabel('\muV');  
datacursormode on; 
dcm_obj = datacursormode(gcf);  
set(dcm_obj,'Enable','on');  
disp('select range for offset with TWO datatips on the waveform, then press ENTER') 
pause; 
c_info = getCursorInfo(dcm_obj); 
    if length(c_info) == 2 
        offset = 
sort(vertcat(c_info(1).Position(1,1),c_info(2).Position(1,1)),'ascend')'; 
        off1 = offset(1,1); 
        off2 = offset(1,2); 
    else disp('WARNING!! not enough/too many datatips inserted: will assign default 
values 0.1 and 0.9 for offset'); 
        off1 = 0.1; 





        off2 = 0.9; 
        pause 
    end 
datacursormode off; 
hold off 
for f = fieldnames(S)' 
    i = S.(f{1}); 
    u = horzcat((i(:,1)-i(1,1))*1.00e+3,i(:,2).*(1000/Mag)); 
    r = horzcat(u(:,1),u(:,2)-mean(u(min(find(u(:,1)> 
off1&u(:,1)<off2)):max(find(u(:,1)>off1&u(:,1)<off2)),2))); 
    r(:,2) = sgolayfilt(r(:,2),4,23); 
    plot(r(:,1),r(:,2)); 
    hold on; 
end 
datacursormode on; 
dcm_obj = datacursormode(gcf);  
set(dcm_obj,'Enable','on');  
disp('select range for CAP Area Analysis, then press ENTER') 
pause; 
c_info2 = getCursorInfo(dcm_obj); 
range = sort(vertcat(c_info2(1).Position(1,1),c_info2(2).Position(1,1)),'ascend')'; 
left = range(1,1); 
right = range(1,2); 
if c_info2(1).Position(1,1)>c_info2(2).Position(1,1); 
    xcap = c_info2(1).Target.XData; 
    ycap = c_info2(1).Target.YData; 
else 
    xcap = c_info2(2).Target.XData; 
    ycap = c_info2(2).Target.YData; 
end 
hold on 
xauc = [xcap(xcap>=left&xcap<right); xcap(xcap>=left&xcap<right); 
xcap(xcap>left&xcap<=right); xcap(xcap>left&xcap<=right)]; 
yauc = [zeros(1,length(xauc)); ycap(xcap>=left&xcap<right); 
ycap(xcap>left&xcap<=right); zeros(1,length(xauc))]; 




f = fieldnames(S)'; 





t0 = S.(char(f(1,1)))(1,1); 
h = 1; 
for f = fieldnames(S)'  
    i = S.(f{1});  
    x1=(i(:,1)-i(1,1)).*1000;   
    cap_time(h)=(i(1,1)-t0)/60;  
    y1=i(:,2).*(1000/Mag); 
    R.(f{1}) = horzcat(x1,y1); 
    cap_range=x1(x1>=left&x1<=right); 
    cap_area(h)=trapz(cap_range,y1(x1>=left&x1<=right)); 
    h = h+1; 
end 
dcm_obj = datacursormode(gcf);  
set(dcm_obj,'Enable','on');  
disp('select range for CAP amplitude-latency Analysis, then press ENTER') 
pause; 
c_info3 = getCursorInfo(dcm_obj); 
range0 = 
sort(vertcat(c_info3(1).Position(1,1),c_info3(2).Position(1,1)),'ascend')'; 
left0 = range0(1,1); 
right0 = range0(1,2); 
    if c_info3(1).Position(1,1)>c_info3(2).Position(1,1); 
        xcap0 = c_info3(1).Target.XData; 
        ycap0 = c_info3(1).Target.YData; 
    else 
        xcap0 = c_info3(2).Target.XData; 
        ycap0 = c_info3(2).Target.YData; 
    end 
h = 1; 
for f = fieldnames(R)' 
    i = R.(f{1});  
    x2=i(:,1);  
    y2=i(:,2); 
    cap_range=x2(x2>=left0&x2<=right0); 
    cap_amplitude(h)=max(y2(x2>=left0&x2<=right0)); 
    cap_latency(h)=mean(x2(y2==max(y2(x2>=left0&x2<=right0)))); 
    h = h+1; 
end 
xauc0 = [xcap0(xcap0>=left0&xcap0<right0); xcap0(xcap0>=left0&xcap0<right0); 
xcap0(xcap0>left0&xcap0<=right0); xcap0(xcap0>left0&xcap0<=right0)]; 





yauc0 = [zeros(1,length(xauc0)); ycap0(xcap0>=left0&xcap0<right0); 
ycap0(xcap0>left0&xcap0<=right0); zeros(1,length(xauc0))]; 
p0 = patch(xauc0,yauc0,[.1 1 .3],'FaceAlpha','.2','EdgeColor','none'); 
cap_time = cap_time'; 
cap_area = cap_area'; 
cap_amplitude = cap_amplitude'; 
cap_latency = cap_latency'; 
  
fig2=figure('Name','CAP Area',... 
    'Color', [0.99 0.99 0.99],... 
    'Position', [100 100 1280 720],... 




    'LineWidth',.1,... 
    'MarkerEdgeColor',[1 0 0],... 
    'MarkerFaceColor',[.9 .3 .3]); 
sz =50; 
scatter(cap_time,cap_amplitude,sz,'filled','o',... 
    'LineWidth',.05,... 
    'MarkerEdgeColor',[0 1 1],... 
    'MarkerFaceColor',[.3 .9 .9]); 
sz =50; 
scatter(cap_time,cap_latency,sz,'filled','s',... 
    'LineWidth',.05,... 
    'MarkerEdgeColor',[1 0 1],... 
    'MarkerFaceColor',[.9 .3 .9]); 
dot_operator = char(8901); 
legend('CAP Area','CAP Amplitude','CAP Latency','Location','best') 
title('CAP Analysis'); 
xlabel('time [min]'); 
ylabel(strcat('\muV',dot_operator,'ms     ',' - ','     \muV    ',' - ','   ms')); 
file = strcat(PathName,strtok(FileName,'.'),'.xlsx'); 
strange = strcat(num2str(range(1,1)),'_ms_',num2str(range(1,2)),'_ms'); 




T = table(cap_time,cap_area,cap_amplitude,cap_latency); 
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7. Kurzfassung (Abstract in German) 
 
Die neuronalen Funktionen hängen entscheidend von einer kontinuierlichen 
Glukosezufuhr ab, da eine anhaltende Hypoglykämie zu schweren Hirnschädigungen führen 
kann. Es ist überraschend, dass das Gehirn außer des astroglialen Glykogens keine sichtbaren 
Energiereserven besitzt. Myelin ist eine lipidreiche Membran, die Axone zur schnellen 
Reizleitung umhüllt. Myelinisierende Oligodendrozyten unterstützen auch den Stoffwechsel 
der Axone. Wir stellten daher die Hypothese auf, dass unter Hungerbedingungen, das Myelin 
selbst den Energiehaushalt der weißen Substanz unterstützen könnte. Am Modell des Sehnervs 
der Maus fanden wir heraus, dass Oligodendrozyten, nicht aber Astrozyten, den Glukoseentzug 
ex vivo bis zu 24 Stunden überleben. Darüber hinaus wurde beobachtet, dass die Myelindicke 
unter Hungerbedingungen abnimmt, unter anderem konnte gezeigt werden, dass die 
Hemmung der Beta-Oxidation einen massiven Zelltod im Sehnerv induziert. Diese 
Beobachtungen deuten darauf hin, dass aus Myelin freigesetzte Fettsäuren an der 
Unterstützung des Zellüberlebens unter Hungerbedingungen beteiligt sind. Maßgeblich ist, 
dass wir mittels Elektrophysiologie in Kombination mit Live-Bildgebung zeigten, dass der 
Fettsäurestoffwechsel die axonale ATP-Produktion und die Nervenleitung durch Störung der 
Beta-Oxidation unterstützt. Diese axonale Unterstützung hängt von der Fettsäure-Beta-
Oxidation ab, an der Peroxisomen im Myelinkompartiment beteiligt sind. Um die reduzierte 
Verfügbarkeit von Glukose in lebenden Mäusen zu untersuchen, haben wir GLUT1 (Slc2a1) aus 
reifen Oligodendrozyten entfernt, was zu einem langsam fortschreitenden Myelinverlust führte. 
Wir schlagen daher ein überarbeitetes Modell für die Doppelfunktion der Oligodendrozyten 
vor, bei dem Myelin einen Energiepuffer bildet, der die axonale Degeneration verhindern kann, 
wenn die Glukoseverfügbarkeit gestört ist. Diese Ergebnisse könnten für Myelin-Anomalien 
relevant sein, die bei einer Reihe von neurodegenerativen Erkrankungen auftreten. 
 
